| | |
PER ADS
|
| |
TOTAL
|
| ||||||
Public offering price
|
| | | $ | 7.00 | | | | | $ | 23,999,997 | | |
承保折扣和佣金(1)
|
| | | $ | 0.42 | | | | | $ | 1,440,000 | | |
未扣除費用的收益
|
| | | $ | 6.58 | | | | | $ | 22,559,997 | | |
| | |
Page
|
| |||
PROSPECTUS SUMMARY
|
| | | | 1 | | |
THE OFFERING
|
| | | | 13 | | |
SUMMARY FINANCIAL DATA
|
| | | | 16 | | |
RISK FACTORS
|
| | | | 18 | | |
有關前瞻性陳述的警示説明
|
| | | | 100 | | |
市場、行業等數據
|
| | | | 102 | | |
USE OF PROCEEDS
|
| | | | 103 | | |
DIVIDEND POLICY
|
| | | | 104 | | |
CAPITALIZATION
|
| | | | 105 | | |
DILUTION
|
| | | | 106 | | |
選定的財務數據
|
| | | | 108 | | |
管理層對財務狀況和經營成果的討論和分析
|
| | | | 110 | | |
BUSINESS
|
| | | | 126 | | |
MANAGEMENT
|
| | | | 204 | | |
關聯方交易
|
| | | | 218 | | |
主要股東
|
| | | | 219 | | |
股本説明
|
| | | | 221 | | |
美國存托股份説明
|
| | | | 234 | | |
未來有資格出售的普通股和美國存託憑證
|
| | | | 242 | | |
TAXATION
|
| | | | 245 | | |
UNDERWRITING
|
| | | | 255 | | |
EXPENSES OF THE OFFERING
|
| | | | 262 | | |
LEGAL MATTERS
|
| | | | 263 | | |
EXPERTS
|
| | | | 264 | | |
訴訟程序的送達和民事責任的執行
|
| | | | 265 | | |
您可以在哪裏找到更多信息
|
| | | | 266 | | |
財務報表索引
|
| | | | F-1 | | |
| | |
For the Years Ended
December 31, |
| |
Three Months Ended
June 30, |
| |
Six Months Ended
June 30, |
| |||||||||||||||||||||||||||||||||
|
(單位為千美元,每股數據除外)
|
| |||||||||||||||||||||||||||||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| |
2020
|
| |
2021
|
| |||||||||||||||||||||||
研發費用
|
| | | $ | 3,729 | | | | | $ | 8,216 | | | | | $ | 10,902 | | | | | $ | 2,570 | | | | | $ | 5,111 | | | | | $ | 5,080 | | | | | $ | 9,004 | | |
一般和行政費用
|
| | | | 1,898 | | | | | | 2,647 | | | | | | 5,666 | | | | | | 1,372 | | | | | | 1,915 | | | | | | 2,153 | | | | | | 3,197 | | |
Operating loss
|
| | | | (5,627) | | | | | | (10,863) | | | | | | (16,568) | | | | | | (3,942) | | | | | | (7,026) | | | | | | (7,233) | | | | | | (12,201) | | |
Finance income
|
| | | | 76 | | | | | | 65 | | | | | | 216 | | | | | | 6 | | | | | | 33 | | | | | | 22 | | | | | | 1,005 | | |
Finance expense
|
| | | | (719) | | | | | | (1,222) | | | | | | 223 | | | | | | — | | | | | | (495) | | | | | | (4) | | | | | | (792) | | |
Net loss before tax
|
| | | | (6,270) | | | | | | (12,020) | | | | | | (16,575) | | | | | | (3,936) | | | | | | (7,488) | | | | | | (7,215) | | | | | | (11,988) | | |
Income taxes
|
| | | | 735 | | | | | | 825 | | | | | | 1,557 | | | | | | 296 | | | | | | 669 | | | | | | 476 | | | | | | 1,076 | | |
Net loss for the period
|
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (15,018) | | | | | $ | (3,640) | | | | | $ | (6,819) | | | | | $ | (6,739) | | | | | $ | (10,912) | | |
Net loss attributable to
equity holders of Evaxion Biotech A/S |
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (15,018) | | | | | $ | (3,640) | | | | | $ | (6,819) | | | | | $ | (6,739) | | | | | $ | (10,912) | | |
Loss per share – basic and diluted(1)
|
| | | $ | (0.43) | | | | | $ | (0.81) | | | | | $ | (0.97) | | | | | $ | (0.24) | | | | | $ | (0.36) | | | | | $ | (0.44) | | | | | $ | (0.59) | | |
(in thousands)
|
| |
June 30, 2021
|
| |||||||||
|
Actual
|
| |
As Adjusted(1)
|
| ||||||||
合併財務狀況表: | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 18,799 | | | | | $ | 40,555 | | |
Total assets
|
| | | | 27,657 | | | | | | 49,149 | | |
Total liabilities
|
| | | | 5,828 | | | | | | 5,828 | | |
Share capital
|
| | | | 3,132 | | | | | | 3,680 | | |
Other reserves
|
| | | | 56,168 | | | | | | 77,112 | | |
Accumulated deficit
|
| | | | (37,471) | | | | | | (37,471) | | |
Total equity
|
| | | $ | 21,829 | | | | | $ | 43,321 | | |
(除每股和每股數據外,以千為單位)
|
| |
As of June 30, 2021
|
| |||||||||
|
Actual
|
| |
As Adjusted
|
| ||||||||
現金和現金等價物
|
| | | $ | 18,799 | | | | | $ | 40,555 | | |
Total liabilities
|
| | | | 5,828 | | | | | | 5,828 | | |
Equity
|
| | | | | | | | | | | | |
Share capital
|
| | | | 3,132 | | | | | | 3,680 | | |
Other reserves
|
| | | | 56,168 | | | | | | 77,112 | | |
Accumulated deficit
|
| | | | (37,471) | | | | | | (37,471) | | |
Total equity
|
| | | | 21,829 | | | | | | 43,321 | | |
Total capitalization(1)
|
| | | $ | 27,657 | | | | | $ | 49,149 | | |
|
每個美國存托股份的公開發行價
|
| | | | | | | | | $ | 7.00 | | |
|
截至2021年6月30日美國存托股份的歷史有形賬面淨值
|
| | | | 1.12 | | | | | | | | |
|
每美國存托股份有形賬面淨值增加可歸因於新投資者參與
in the offering |
| | | | 0.79 | | | | | | | | |
|
美國存托股份上市後的調整後有形賬面淨值
|
| | | | | | | | | | 1.91 | | |
|
按美國存托股份向參與此次發行的新投資者攤薄
|
| | | | | | | | | $ | 5.09 | | |
| | |
Ordinary Shares
Purchased |
| |
Total Consideration
|
| |
Average
Price Per Share |
| |
Average
Price Per ADS |
| ||||||||||||||||||||||||
|
Number
|
| |
Percent
|
| |
Amount
|
| |
Percent
|
| ||||||||||||||||||||||||||
現有股東
|
| | | | 19,198,668 | | | | | | 84.8% | | | | | $ | 59,300,000 | | | | | | 71.2% | | | | | $ | 3.09 | | | | | $ | 3.09 | | |
New investors
|
| | | | 3,428,571 | | | | | | 15.2% | | | | | | 23,999,997 | | | | | | 28.8% | | | | | $ | 7.00 | | | | | $ | 7.00 | | |
Total
|
| | | | 22,627,239 | | | | | | 100% | | | | | $ | 83,299,997 | | | | | | 100% | | | | | $ | 3.68 | | | | | $ | 3.68 | | |
| | |
For the Years Ended
December 31, |
| |
Three Months Ended
June 30, |
| |
Six Months Ended
June 30, |
| |||||||||||||||||||||||||||||||||
|
(單位為千美元,每股數據除外)
|
| |||||||||||||||||||||||||||||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |
2020
|
| |
2021
|
| |
2020
|
| |
2021
|
| |||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | |
(unaudited)
|
| |
(unaudited)
|
| ||||||||||||||||||||
研發費用
|
| | | $ | 3,729 | | | | | $ | 8,216 | | | | | $ | 10,902 | | | | | $ | 2,570 | | | | | $ | 5,111 | | | | | $ | 5,080 | | | | | $ | 9,004 | | |
一般和行政費用
|
| | | | 1,898 | | | | | | 2,647 | | | | | | 5,666 | | | | | | 1,372 | | | | | | 1,915 | | | | | | 2,153 | | | | | | 3,197 | | |
Operating loss
|
| | | | (5,627) | | | | | | (10,863) | | | | | | (16,568) | | | | | | (3,942) | | | | | | (7,026) | | | | | | (7,233) | | | | | | (12,201) | | |
Finance income
|
| | | | 76 | | | | | | 65 | | | | | | 216 | | | | | | 6 | | | | | | 33 | | | | | | 22 | | | | | | 1,005 | | |
Finance expense
|
| | | | (719) | | | | | | (1,222) | | | | | | (223) | | | | | | — | | | | | | (495) | | | | | | (4) | | | | | | (792) | | |
Net loss before tax
|
| | | | (6,270) | | | | | | (12,020) | | | | | | (16,575) | | | | | | (3,936) | | | | | | (7,488) | | | | | | (7,215) | | | | | | (11,988) | | |
Income taxes
|
| | | | 735 | | | | | | 825 | | | | | | 1,557 | | | | | | 296 | | | | | | 669 | | | | | | 476 | | | | | | 1,076 | | |
Net loss for the period
|
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (15,018) | | | | | $ | (3,640) | | | | | $ | (6,819) | | | | | $ | (6,739) | | | | | $ | (10,912) | | |
Net loss attributable to
equity holders of Evaxion Biotech A/S |
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (15,018) | | | | | $ | (3,640) | | | | | $ | (6,819) | | | | | $ | (6,739) | | | | | $ | (10,912) | | |
Loss per share – basic and diluted
|
| | | $ | (0.43) | | | | | $ | (0.81) | | | | | $ | (0.97) | | | | | $ | (0.24) | | | | | $ | (0.36) | | | | | $ | (0.44) | | | | | $ | (0.59) | | |
(in thousands)
|
| |
As of
|
| |||||||||||||||||||||
|
December 31,
|
| |
June 30,
|
| ||||||||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |
2021
|
| ||||||||||||||
| | | | | | | | | | | | | | | | | | |
(unaudited)
|
| |||||
合併財務狀況表: | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 7,433 | | | | | $ | 9,559 | | | | | $ | 5,834 | | | | | | 18,799 | | |
Total assets
|
| | | | 8,513 | | | | | | 11,084 | | | | | | 11,965 | | | | | $ | 27,657 | | |
Total liabilities
|
| | | | 9,444 | | | | | | 1,722 | | | | | | 4,927 | | | | | | 5,828 | | |
Share capital
|
| | | | 2,113 | | | | | | 2,481 | | | | | | 2,648 | | | | | $ | 3,132 | | |
Other reserves
|
| | | | 3,935 | | | | | | 22,693 | | | | | | 31,669 | | | | | | 56,168 | | |
Accumulated deficit
|
| | | | (6,979) | | | | | | (15,812) | | | | | | (27,279) | | | | | | (37,471) | | |
Total equity
|
| | | | (931) | | | | | | 9,362 | | | | | | 7,038 | | | | | | 21,829 | | |
| | |
Three Months Ended June 30,
|
| |||||||||||||||
| | |
2020
|
| |
2021
|
| |
Change
|
| |||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
Operating expenses: | | | | | | | | | | | | | | | | | | | |
研發
|
| | | $ | 2,570 | | | | | $ | 5,111 | | | | | $ | 2,541 | | |
一般和行政
|
| | | | 1,372 | | | | | | 1,915 | | | | | | 543 | | |
總運營費用
|
| | | | 3,942 | | | | | | 7,026 | | | | | | 3,084 | | |
Operating loss
|
| | | | (3,942) | | | | | | (7,026) | | | | | | (3,084) | | |
Finance income
|
| | | | 6 | | | | | | 33 | | | | | | 27 | | |
Finance expenses
|
| | | | — | | | | | | (495) | | | | | | (495) | | |
Net loss before tax
|
| | | | (3,936) | | | | | | (7,488) | | | | | | (3,552) | | |
Income tax benefit
|
| | | | 296 | | | | | | 669 | | | | | | 373 | | |
Net loss for the period
|
| | | $ | (3,640) | | | | | $ | (6,819) | | | | | $ | (3,179) | | |
| | |
Six Months Ended June 30,
|
| |||||||||||||||
|
2020
|
| |
2021
|
| |
Change
|
| |||||||||||
|
(USD in thousands)
|
| |||||||||||||||||
Operating expenses: | | | | | | | | | | | | | | | | | | | |
研發
|
| | | $ | 5,080 | | | | | $ | 9,004 | | | | | $ | 3,924 | | |
一般和行政
|
| | | | 2,153 | | | | | | 3,197 | | | | | | 1,044 | | |
總運營費用
|
| | | | 7,233 | | | | | | 12,201 | | | | | | 4,968 | | |
Operating loss
|
| | | | (7,233) | | | | | | (12,201) | | | | | | (4,968) | | |
Finance income
|
| | | | 22 | | | | | | 1,005 | | | | | | 983 | | |
Finance expenses
|
| | | | (4) | | | | | | (792) | | | | | | (788) | | |
Net loss before tax
|
| | | | (7,215) | | | | | | (11,988) | | | | | | (4,773) | | |
Income tax benefit
|
| | | | 476 | | | | | | 1,076 | | | | | | 600 | | |
Net loss for the period
|
| | | $ | (6,739) | | | | | $ | (10,912) | | | | | $ | (4,173) | | |
| | |
Years Ended December 31,
|
| |
Change
2019 vs 2018 |
| |
Change
2020 vs 2019 |
| |||||||||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |||||||||||||||||||||||
|
(USD in thousands)
|
| |||||||||||||||||||||||||||||
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
研發
|
| | | $ | 3,729 | | | | | $ | 8,216 | | | | | $ | 10,902 | | | | | $ | 4,487 | | | | | $ | 2,686 | | |
一般和行政
|
| | | | 1,898 | | | | | | 2,647 | | | | | | 5,666 | | | | | | 749 | | | | | | 3,019 | | |
總運營費用
|
| | | | 5,627 | | | | | | 10,863 | | | | | | 16,568 | | | | | | 5,236 | | | | | | 5,705 | | |
Operating loss
|
| | | | (5,627) | | | | | | (10,863) | | | | | | (16,568) | | | | | | (5,236) | | | | | | (5,705) | | |
Finance income
|
| | | | 76 | | | | | | 65 | | | | | | 216 | | | | | | (11) | | | | | | 151 | | |
Finance expenses
|
| | | | (719) | | | | | | (1,222) | | | | | | (223) | | | | | | (503) | | | | | | 999 | | |
Net loss before tax
|
| | | | (6,270) | | | | | | (12,020) | | | | | | (16,575) | | | | | | (5,750) | | | | | | (4,555) | | |
Income taxes
|
| | | | 735 | | | | | | 825 | | | | | | 1,557 | | | | | | 90 | | | | | | 732 | | |
Net loss for the period
|
| | | $ | (5,535) | | | | | $ | (11,195) | | | | | $ | (15,018) | | | | | $ | (5,660) | | | | | $ | (3,823) | | |
| | |
Six Months Ended June 30,
|
| |||||||||
|
2020
|
| |
2021
|
| ||||||||
|
(USD in thousands)
|
| |||||||||||
Cash Flow Data: | | | | | | | | | | | | | |
經營活動中使用的淨現金
|
| | | $ | (5,253) | | | | | $ | (11,523) | | |
投資活動中使用的淨現金
|
| | | | (126) | | | | | | (822) | | |
淨現金(用於)/由融資活動提供
|
| | | | (36) | | | | | | 25,217 | | |
現金和現金等價物淨增加/(減少)
|
| | | $ | (5,415) | | | | | $ | (12,872) | | |
| | |
Years Ended December 31,
|
| |||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |||||||||||
|
(USD in thousands)
|
| |||||||||||||||||
Cash Flow Data: | | | | | | | | | | | | | | | | | | | |
經營活動中使用的現金
|
| | | $ | (1,991) | | | | | $ | (7,019) | | | | | $ | (12,438) | | |
投資活動提供/使用的現金
|
| | | | 6 | | | | | | (68) | | | | | | (393) | | |
融資活動提供的現金
|
| | | | 9,027 | | | | | | 9,508 | | | | | | 8,818 | | |
現金及現金等價物淨增(減)
|
| | | $ | 7,042 | | | | | $ | 2,421 | | | | | $ | (4,013) | | |
(USD in thousands)
|
| |
June 30, 2021
|
| |||||||||||||||||||||||||||||||||
|
Carrying
amount |
| |
Contractual
cash flows |
| |
|
| |
1 – 5 years
|
| |
>5 years
|
| |
Total
|
| ||||||||||||||||||||
Lease liabilities
|
| | | $ | 1,110 | | | | | $ | 1,641 | | | | | $ | 141 | | | | | $ | 592 | | | | | $ | 908 | | | | | $ | 1,641 | | |
Trade payables
|
| | | | 1,552 | | | | | | 1,552 | | | | | | 1,552 | | | | | | — | | | | | | — | | | | | | 1,552 | | |
Other payables
|
| | | | 3,113 | | | | | | 3,113 | | | | | | 3,113 | | | | | | — | | | | | | — | | | | | | 3,113 | | |
Total
|
| | | $ | 5,775 | | | | | $ | 6,306 | | | | | $ | 4,806 | | | | | $ | 592 | | | | | $ | 908 | | | | | $ | 6,306 | | |
| | |
Per warrant
grant date fair value (DKK) |
| |
Per warrant
grant date fair value (USD) |
| ||||||
優秀項目 | | | | | | | | | | | | | |
Grant (December 2016)
|
| | | | 20.91 | | | | | | 3.13 | | |
Grant (April 2017)
|
| | | | 24.05 | | | | | | 3.60 | | |
Grant (September 2017)
|
| | | | 28.71 | | | | | | 4.30 | | |
Grant (December 2017)
|
| | | | 28.71 | | | | | | 4.30 | | |
Granted (during 2018)
|
| | | | 37.05 | | | | | | 5.55 | | |
Granted (January 2019)
|
| | | | 37.05 | | | | | | 5.55 | | |
| | |
Per warrant
grant date fair value (DKK) |
| |
Per warrant
grant date fair value (USD) |
| ||||||
Granted (February 2019)
|
| | | | 42.57 | | | | | | 6.38 | | |
Granted (September 2019)
|
| | | | 56.35 | | | | | | 8.44 | | |
Granted (October 2019)
|
| | | | 56.97 | | | | | | 8.53 | | |
Granted (December 2019)
|
| | | | 57.48 | | | | | | 8.60 | | |
Granted (December 2020)
|
| | | | 56.75 | | | | | | 9.35 | | |
|
|
| |
|
|
Bacterial species
|
| |
In vivo
PoC |
| |
體內模型(小鼠挑戰模型)
|
| |
IP
filed |
|
金黃色葡萄球菌
|
| |
✓
|
| |
致死性腹膜炎和皮膚膿腫模型
|
| |
✓
|
|
銅綠假單胞菌
|
| |
✓
|
| | 致死性腹膜炎和致死性急性肺炎模型 | | |
✓
|
|
非分型流感嗜血桿菌
|
| |
✓
|
| | 肺定植模型 | | |
✓
|
|
卡他莫拉氏菌
|
| |
✓
|
| | 致死性腹膜炎和肺定植模型 | | |
✓
|
|
淋病奈瑟菌
|
| |
✓
|
| | 陰道定植模型 | | |
✓
|
|
鮑曼不動桿菌
|
| |
✓
|
| | 致死性急性肺炎模型 | | |
✓
|
|
肺炎克雷伯菌
|
| |
✓
|
| | 致死性腹膜炎和致死性急性肺炎模型 | | |
✓
|
|
#
|
| |
Protein ID
|
| |
No. of
Experiments |
| |
No. of
Test Mice |
| |
No. of
Control Mice |
| |
%
Survival of Test Mice |
| |
%
Survival of Control Mice |
| |
Difference in
% Survival (Test vs. Control) |
| ||||||||||||||||||
1 | | | EDEN-1 | | | | | 4 | | | | | | 59 | | | | | | 60 | | | | | | 76% | | | | | | 28% | | | | | | 48% | | |
2 | | | EDEN-2 | | | | | 2 | | | | | | 24 | | | | | | 24 | | | | | | 58% | | | | | | 13% | | | | | | 46% | | |
3 | | | EDEN-3 | | | | | 3 | | | | | | 43 | | | | | | 44 | | | | | | 77% | | | | | | 32% | | | | | | 45% | | |
4 | | | EDEN-4 | | | | | 2 | | | | | | 28 | | | | | | 28 | | | | | | 68% | | | | | | 25% | | | | | | 43% | | |
5 | | | EDEN-5 | | | | | 2 | | | | | | 28 | | | | | | 28 | | | | | | 68% | | | | | | 25% | | | | | | 43% | | |
6 | | | EDEN-6 | | | | | 2 | | | | | | 27 | | | | | | 28 | | | | | | 85% | | | | | | 43% | | | | | | 42% | | |
7 | | | EDEN-7 | | | | | 3 | | | | | | 36 | | | | | | 36 | | | | | | 61% | | | | | | 19% | | | | | | 42% | | |
8 | | | EDEN-8 | | | | | 5 | | | | | | 61 | | | | | | 64 | | | | | | 51% | | | | | | 9% | | | | | | 41% | | |
9 | | | EDEN-9 | | | | | 3 | | | | | | 43 | | | | | | 44 | | | | | | 63% | | | | | | 30% | | | | | | 33% | | |
10 | | | EDEN-10 | | | | | 3 | | | | | | 36 | | | | | | 36 | | | | | | 69% | | | | | | 36% | | | | | | 33% | | |
11 | | | EDEN-11 | | | | | 3 | | | | | | 32 | | | | | | 35 | | | | | | 53% | | | | | | 20% | | | | | | 33% | | |
12 | | | EDEN-12 | | | | | 3 | | | | | | 42 | | | | | | 42 | | | | | | 62% | | | | | | 31% | | | | | | 31% | | |
13 | | | EDEN-13 | | | | | 3 | | | | | | 36 | | | | | | 36 | | | | | | 47% | | | | | | 28% | | | | | | 19% | | |
Function
|
| |
Number
|
| |||
臨牀研究與開發
|
| | | | 9 | | |
科學研究與開發
|
| | | | 33 | | |
Supporting Functions
|
| | | | 10 | | |
商業和商業發展
|
| | | | 5 | | |
TOTAL
|
| | |
|
57
|
| |
Region
|
| |
Number
|
| |||
Capital Region, Denmark
|
| | | | 55 | | |
New York, United States
|
| | | | 2 | | |
TOTAL
|
| | |
|
57
|
| |
Name
|
| |
Position
|
| |
Age
|
| |
Independent
|
| |
Year of first
appointment |
| |
Expiration
of current term |
| ||||||||||||
Marianne Søgaard(1)
|
| | | | 女主席 | | | | 53 | | | No | | | | | 2020 | | | | | | 2022 | | | |||
Steven Projan(1)(2)(3)
|
| | Member | | | 69 | | | | | 獨立的 | | | | | | 2018 | | | | | | 2022 | | | |||
Roberto Prego(1)(2)
|
| | Member | | | 50 | | | | | 獨立的 | | | | | | 2018 | | | | | | 2022 | | | |||
Lars Holtug(2)(3)
|
| | Member | | | 62 | | | | | 獨立的 | | | | | | 2021 | | | | | | 2022 | | |
Name
|
| |
Age
|
| |
Position(s)
|
|
執行管理層: | | | | | | | |
Lars Staal Wegner, M.D.
|
| | 47 | | | 首席執行官 | |
Niels Iversen Møller, M.D.
|
| | 42 | | | 臨時首席財務官兼首席業務官 | |
Glenn S. Vraniak(1)
|
| | 59 | | | 前首席財務官 | |
Erik Deichmann Heegaard,博士,DMSc
|
| | 54 | | | 首席醫療官 | |
Birgitte Rønø, Ph.D.
|
| | 45 | | | 首席科學官 | |
Andreas Holm Mattsson
|
| | 46 | | | 首席創新官 | |
(in thousands of USD)
|
| |
Years Ended
December 31, |
| |||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |||||||||||
Lars Staal Wegner(CEO) | | | | | | | | | | | | | | | | | | | |
Salary
|
| | | | 220 | | | | | | 238 | | | | | | 321 | | |
Bonus
|
| | | | 6 | | | | | | – | | | | | | – | | |
其他員工福利
|
| | | | – | | | | | | 650 | | | | | | 621 | | |
Total
|
| | | | 226 | | | | | | 888 | | | | | | 942 | | |
Glenn S. Vraniak (CFO)(1) | | | | | | | | | | | | | | | | | | | |
Salary
|
| | | | – | | | | | | 88 | | | | | | 350 | | |
Bonus
|
| | | | – | | | | | | – | | | | | | 43 | | |
Other employee benefits(2)
|
| | | | – | | | | | | 204 | | | | | | 1,045 | | |
Total
|
| | | | – | | | | | | 292 | | | | | | 1,438 | | |
Niels Iverson Møller (CBO)(3) | | | | | | | | | | | | | | | | | | | |
Salary
|
| | | | 173 | | | | | | 175 | | | | | | 202 | | |
Bonus
|
| | | | 5 | | | | | | – | | | | | | 11 | | |
其他員工福利
|
| | | | – | | | | | | – | | | | | | 0 | | |
Total
|
| | | | 178 | | | | | | 175 | | | | | | 213 | | |
安德烈亞斯·霍姆·馬特森(CIO) | | | | | | | | | | | | | | | | | | | |
Salary
|
| | | | 179 | | | | | | 175 | | | | | | 202 | | |
(in thousands of USD)
|
| |
Years Ended
December 31, |
| |||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |||||||||||
Bonus
|
| | | | 5 | | | | | | – | | | | | | 11 | | |
其他員工福利
|
| | | | – | | | | | | – | | | | | | 0 | | |
Total
|
| | | | 184 | | | | | | 175 | | | | | | 213 | | |
Erik Deichmann Heegaard,Ph.D.,DMSc(CMO)(3) | | | | | | | | | | | | | | | | | | | |
Salary
|
| | | | – | | | | | | – | | | | | | – | | |
Bonus
|
| | | | – | | | | | | – | | | | | | – | | |
其他員工福利
|
| | | | – | | | | | | – | | | | | | – | | |
Total
|
| | | | – | | | | | | – | | | | | | – | | |
Birgitte Rønø, Ph.D. | | | | | | | | | | | | | | | | | | | |
Salary
|
| | | | 113 | | | | | | 131 | | | | | | 159 | | |
Bonus
|
| | | | – | | | | | | – | | | | | | – | | |
其他員工福利
|
| | | | 14 | | | | | | 30 | | | | | | 68 | | |
Total
|
| | | | 127 | | | | | | 161 | | | | | | 227 | | |
|
(in thousands of USD)
|
| |
Years Ended
December 31, |
| |||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |||||||||||
不包括執行管理層和董事會的員工成本
|
| | | | | | | | | | | | | | | | | | |
Salaries
|
| | | | 1,112 | | | | | | 1,919 | | | | | | 2,717 | | |
Cash bonus
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | 387 | | | | | | 1,055 | | | | | | 1,484 | | |
Pensions
|
| | | | 70 | | | | | | 96 | | | | | | 206 | | |
其他社保繳費
|
| | | | 10 | | | | | | 12 | | | | | | 17 | | |
Other staff costs
|
| | | | 133 | | | | | | 176 | | | | | | 196 | | |
員工總成本,不包括執行管理層和董事會
|
| | | | 1,712 | | | | | | 3,258 | | | | | | 4,620 | | |
高管薪酬 | | | | | | | | | | | | | | | | | | | |
Salaries
|
| | | | 621 | | | | | | 900 | | | | | | 1,234 | | |
Cash bonus
|
| | | | – | | | | | | – | | | | | | 65 | | |
基於股份的薪酬
|
| | | | 1,157 | | | | | | 956 | | | | | | 1,565 | | |
Pensions
|
| | | | – | | | | | | – | | | | | | – | | |
其他社保繳費
|
| | | | – | | | | | | – | | | | | | – | | |
Other staff costs
|
| | | | – | | | | | | – | | | | | | – | | |
高管薪酬總額
|
| | | | 1,778 | | | | | | 1,856 | | | | | | 2,864 | | |
董事會薪酬 | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
(in thousands of USD)
|
| |
Years Ended
December 31, |
| |||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |||||||||||
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | 525 | | | | | | 351 | | | | | | 359 | | |
董事會薪酬總額
|
| | | | 525 | | | | | | 351 | | | | | | 359 | | |
Total employee costs
|
| | | | 4,015 | | | | | | 5,465 | | | | | | 7,843 | | |
在全面損失表中確認如下: | | | | | | | | | | | | | | | | | | | |
研發費用
|
| | | | 2,652 | | | | | | 3,607 | | | | | | 4,833 | | |
一般和行政費用
|
| | | | 1,363 | | | | | | 1,858 | | | | | | 3,007 | | |
Total employee costs
|
| | | | 4,015 | | | | | | 5,465 | | | | | | 7,840 | | |
全職員工平均人數
|
| | | | 18 | | | | | | 25 | | | | | | 33 | | |
截至12月31日的全職員工人數
|
| | | | 20 | | | | | | 36 | | | | | | 35 | | |
(in thousands in USD)
|
| |
Years Ended
December 31, |
| |||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |||||||||||
Marianne Søgaard(1) | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | – | | | | | | – | | | | | | 12 | | |
Total
|
| | | | – | | | | | | – | | | | | | 12 | | |
Kim Bjoernstrup(董事會主席)(2) | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | – | | | | | | – | | | | | | 52 | | |
Total
|
| | | | – | | | | | | – | | | | | | 52 | | |
Helen M. Boudreau(3) | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | – | | | | | | – | | | | | | 48 | | |
Total
|
| | | | – | | | | | | – | | | | | | 48 | | |
Roberto Prego | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | – | | | | | | 61 | | | | | | 62 | | |
Total
|
| | | | – | | | | | | 61 | | | | | | 62 | | |
Steven Projan | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | 138 | | | | | | 62 | | | | | | 98 | | |
Total
|
| | | | 138 | | | | | | 62 | | | | | | 98 | | |
Jo Ann Suzich(4) | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
(in thousands in USD)
|
| |
Years Ended
December 31, |
| |||||||||||||||
|
2018
|
| |
2019
|
| |
2020
|
| |||||||||||
基於股份的薪酬
|
| | | | – | | | | | | 63 | | | | | | 26 | | |
Total
|
| | | | – | | | | | | 63 | | | | | | 26 | | |
託馬斯·威廉·威隆尼斯 | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | – | | | | | | 166 | | | | | | 60 | | |
Total
|
| | | | – | | | | | | 166 | | | | | | 60 | | |
Lars Holtug(4) | | | | | | | | | | | | | | | | | | | |
Board and committee fees
|
| | | | – | | | | | | – | | | | | | – | | |
Travel allowance
|
| | | | – | | | | | | – | | | | | | – | | |
基於股份的薪酬
|
| | | | – | | | | | | – | | | | | | – | | |
Total
|
| | | | – | | | | | | – | | | | | | – | | |
|
Name
|
| |
Grant Date
|
| |
Number of Ordinary
Shares Underlying Warrants(2) |
| |
Warrant
Exercise Price DKK |
| |
Warrant
Expiration Date |
| |||
Marianne Søgaard
(Chairwoman) |
| | 2018/2019/2020 | | | | | 94,320 | | | |
1
|
| |
December 31, 2036
|
|
Lars Holtug (director)
|
| | 2021 | | | | | 0 | | | |
1
|
| |
–
|
|
Roberto Prego (director)
|
| | 2017/2018/2020 | | | | | 27,036 | | | |
1
|
| |
December 31, 2036
|
|
Steven Projan (director)
|
| | 2018/2019/2020 | | | | | 42,048 | | | |
1
|
| |
December 31, 2036
|
|
Lars Staal Wegner (CEO)
|
| | 2016/2017/2018/2020 | | | | | 852,264 | | | |
1
|
| |
December 31, 2036
|
|
Niels Iverson Møller (CBO)
|
| | – | | | | | 0 | | | |
–
|
| |
–
|
|
Andreas Holm Mattson (CIO)
|
| | – | | | | | 0 | | | |
–
|
| |
–
|
|
Glenn S. Vraniak (CFO)(1)
|
| | 2019 | | | | | 150,660 | | | |
1
|
| |
December 31, 2036
|
|
Erik Deichmann Heegaard(CMO)
|
| | 2021 | | | | | 62,147 | | | |
1
|
| |
December 31, 2031
|
|
Birgitte Rønø (CSO)
|
| | 2017/2018/2019/2020 | | | | | 29,376 | | | |
1
|
| |
December 31, 2036
|
|
Board Member
|
| |
Position
|
| |
Committees
|
| |
Retainer
|
| |||
Marianne Søgaard
|
| | Chairwoman | | | 提名和治理 | | | | $ | 120,667 | | |
Roberto Prego
|
| | Director | | |
提名和治理審計委員會
|
| | | $ | 40,000 | | |
Steven Projan
|
| | Director | | | 審計委員會,薪酬 | | | | $ | 58,542 | | |
Lars Holtug
|
| | Director | | | 審計委員會,薪酬 | | | | $ | 54,875 | | |
Name of Beneficial Owner
|
| |
實益擁有的股份
before The Offering |
| |
實益擁有的股份
after The Offering |
| |
Percent of Shares
Beneficially Owned Assuming Full Exercise of Underwriters’ Option to Purchase Additional Shares |
| |||||||||||||||||||||
|
Number
|
| |
Percent
|
| |
Number
|
| |
Percent
|
| ||||||||||||||||||||
5%或更大股東 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
NIMedical Holding ApS(1)
|
| | | | 4,292,604 | | | | | | 22.36 | | | | | | 4,292,604 | | | | | | 18.97 | | | | | | 18.55 | | |
Mattsson Holding af 2008 ApS(2)
|
| | | | 4,163,832 | | | | | | 21.69 | | | | | | 4,163,832 | | | | | | 18.40 | | | | | | 17.99 | | |
Executive Management
|
| | | | | | | | | | | | | | | | | | | | | | 3.65 | | | | | | 3.57 | | |
Lars Staal Wegner
|
| | | | 182,124 | | | | | | * | | | | | | 182,124 | | | | | | * | | | | | | * | | |
Niels Iverson Møller(1)
|
| | | | 4,292,604 | | | | | | 22.36 | | | | | | 4,292,604 | | | | | | 18.97 | | | | | | 18.55 | | |
Andreas Holm Mattson(2)
|
| | | | 4,163,832 | | | | | | 21.69 | | | | | | 4,163,832 | | | | | | 18.40 | | | | | | 17.99 | | |
Glenn S. Vraniak(3)
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | |
Birgitte Rønø
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | |
Erik Deichmann Heegaard
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | |
Directors | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Roberto Prego
|
| | | | 310,248 | | | | | | 1.62 | | | | | | 310,248 | | | | | | 1.37 | | | | | | 1.34 | | |
Steven Projan
|
| | | | 27,288 | | | | | | * | | | | | | 27,288 | | | | | | * | | | | | | * | | |
Lars Holtug
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | |
Marianne Søgaard
|
| | | | 41,652 | | | | | | * | | | | | | 41,652 | | | | | | * | | | | | | * | | |
所有現任董事和執行管理層,作為一個小組(10人)
|
| | | | 9,017,748 | | | | | | 46.97 | | | | | | 9,017,748 | | | | | | 39.85 | | | | | | 38.97 | | |
Date
|
| |
Transaction
|
| |
Share Capital
After Transaction |
| |
Price
Per share (DKK) |
| ||||||
August 2008
|
| | Formation (Nominal DKK 1) | | | | | 250,000 | | | | | | 1.00 | | |
March 2014
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 268,148 | | | | | | 120.00 | | |
December 2014
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 316,751 | | | | | | 178.22 | | |
December 2015
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 336,549 | | | | | | 435.76 | | |
March 2016
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 342,880 | | | | | | 432.12 | | |
September 2017
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 358,806 | | | | | | 1,034.75 | | |
March 2019
|
| | 轉移儲備(名義1丹麥克朗) | | | | | 717,612 | | | | | | 1.00 | | |
July 2019
|
| |
現金出資和債務轉換
(Nominal DKK 1) |
| | | | 836,994 | | | |
914.71(avg)
|
| |||
December 2019
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 843,564 | | | | | | 1,037.50 | | |
September 2020
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 884,974 | | | | | | 1,002.90 | | |
October 2020
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 899,926 | | | | | | 1,008.45 | | |
January 2021
|
| | Share split 2-for-1 (Nominal DKK 1) | | | | | 899,926 | | | | | | – | | |
January 2021
|
| |
1送17(名義1丹麥克朗)紅股發行
|
| | | | 16,198,668 | | | | | | – | | |
February 2021
|
| | 現金貢獻(名義上為1丹麥克朗) | | | | | 19,198,668 | | | | | | 61.84 | | |
June 2021
|
| | | | | | | | | | | | | | | |
Grant Date
|
| |
Vesting Period
|
| |
Expiration Date
|
| |
Exercise Price
|
| |
Number of Warrants
|
| |||
December 19, 2016
|
| |
Fully Vested
|
| |
December 31, 2036
|
| | | | DKK1.0 | | | |
758,448
|
|
December 10, 2017
|
| |
Fully Vested
|
| |
December 31, 2036
|
| | | | DKK1.0 | | | |
632,700
|
|
December 19, 2017
|
| |
Fully Vested
|
| |
December 31, 2036
|
| | | | DKK1.0 | | | |
141,804
|
|
December 17, 2020
|
| |
Upon Exit/1/36 per month
|
| |
December 31, 2036
|
| | | | DKK1.0 | | | |
757,620
|
|
June 17, 2021
未經鍛鍊即失效或作廢 |
| |
1/36 per month
|
| |
December 31, 2031
|
| | | | DKK1.0 | | | |
62,147
(79,112)
2,273,607
|
|
存取款人員
股票或美國存托股份持有人必須支付: |
| |
For:
|
|
$5.00 (or less) per 100 ADSs (or portion of 100 ADSs) | | |
美國存託憑證的發行,包括因股份、權利或其他財產的分配而產生的發行
為取款目的取消美國存託憑證,包括存款協議終止的情況
|
|
$.05 (or less) per ADS | | | 對美國存托股份持有者的任何現金分配 | |
如果分發給您的證券是股票,並且這些股票是為發行美國存託憑證而存放的,則應支付的費用相當於該費用 | | | 由託管人分配給美國存托股份持有人的分配給已存放證券(包括權利)持有人的證券的分配 | |
每個日曆年每個美國存托股份$0.05(或更少) | | | 託管服務 | |
註冊費或轉讓費 | | | 當您存入或提取股票時,我們股票登記簿上的股票以託管人或其代理人的名義進行轉讓和登記 | |
託管人的費用 | | |
電報和傳真傳輸(如果存款協議中明確規定)
將外幣兑換成美元
|
|
託管人或託管人必須為任何美國存託憑證或股票支付的税款和其他政府費用,如股票轉讓税、印花税或預扣税 | | | As necessary | |
託管人或其代理人為已交存證券支付的任何費用 | | | As necessary | |
Underwriter
|
| |
Number of
ADSs |
| |||
Oppenheimer & Co. Inc.
|
| | | | 2,400,000 | | |
Ladenburg Thalmann & Co. Inc.
|
| | | | 600,000 | | |
Lake Street Capital Markets,LLC
|
| | | | 428,571 | | |
Total
|
| | | | 3,428,571 | | |
| | |
Per ADS
|
| |
Total
Without Exercise of Over-Allotment Option |
| |
Total With
Full Exercise of Over-Allotment Option |
| |||||||||
Public offering price
|
| | | $ | 7.00 | | | | | $ | 23,999,997 | | | | | $ | 27,599,992 | | |
承保折扣和佣金
|
| | | $ | 0.42 | | | | | $ | 1,440,000 | | | | | $ | 1,656,000 | | |
未扣除費用的收益給我們
|
| | | $ | 6.58 | | | | | $ | 22,559,997 | | | | | $ | 25,943,992 | | |
Expenses
|
| |
Amount
|
| |||
SEC registration fee
|
| | | $ | 2,559 | | |
FINRA filing fee
|
| | | | 15,500 | | |
印刷費和雕刻費
|
| | | | 190,000 | | |
Legal fees and expenses
|
| | | | 550,000 | | |
會計費和費用
|
| | | | 300,000 | | |
雜項費用
|
| | | | 10,000 | | |
Total
|
| | | $ | 1,068,059 | | |
| | |
Page
|
| |||
經審計的財務報表: | | | | | | | |
獨立註冊會計師事務所報告
|
| | | | F-2 | | |
Financial Statements:
|
| | | | | | |
截至2018年、2019年和2020年12月31日止年度的全面虧損表
|
| | | | F-3 | | |
截至2019年和2020年12月31日的財務狀況表
|
| | | | F-4 | | |
截至2018年、2019年和2020年12月31日止年度的權益變動表
|
| | | | F-5 | | |
截至2018年、2019年和2020年12月31日止年度的現金流量表
|
| | | | F-6 | | |
財務報表附註
|
| | | | F-7 | | |
|
三個年度未經審計的簡明合併中期綜合損失表
and Six Months Ended June 30, 2021 and 2020 |
| | | | F-38 | | |
|
截至2021年6月30日和2020年12月31日的未經審計簡明合併中期財務報表
|
| | | | F-39 | | |
|
第三和第六年度未經審計的簡明合併中期權益變動表
Months Ended June 30, 2021 and 2020 |
| | | | F-40 | | |
|
截至2021年6月30日和2020年6月30日的六個月未經審計的簡明合併中期現金流表
|
| | | | F-41 | | |
|
未經審計的簡明合併中期財務報表附註
|
| | | | F-42 | | |
| | | | | |
Years Ended December 31,
|
| |||||||||||||||
| | |
Note
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(單位為千美元,每股除外)
|
| ||||||||||||||||||
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | |
研發
|
| |
6,7
|
| | | $ | 10,902 | | | | | $ | 8,216 | | | | | $ | 3,729 | | |
一般和行政
|
| |
6,7
|
| | | | 5,666 | | | | | | 2,647 | | | | | | 1,898 | | |
總運營費用
|
| | | | | | | 16,568 | | | | | | 10,863 | | | | | | 5,627 | | |
Operating loss
|
| | | | | | | (16,568) | | | | | | (10,863) | | | | | | (5,627) | | |
Finance income
|
| |
9
|
| | | | 216 | | | | | | 65 | | | | | | 76 | | |
Finance expenses
|
| |
9
|
| | | | (223) | | | | | | (1,222) | | | | | | (719) | | |
Net loss before tax
|
| | | | | | | (16,575) | | | | | | (12,020) | | | | | | (6,270) | | |
Income tax benefit
|
| |
10
|
| | | | 1,557 | | | | | | 825 | | | | | | 735 | | |
Net loss for the year
|
| | | | | | $ | (15,018) | | | | | $ | (11,195) | | | | | $ | (5,535) | | |
Evaxion Biotech A/S股東應佔淨虧損
|
| | | | | | $ | (15,018) | | | | | $ | (11,195) | | | | | $ | (5,535) | | |
可重新分類為利潤或
的其他全面收入
後續期間虧損(税後淨額): |
| | | | | | | | | | | | | | | | | | | | | |
對外業務翻譯匯兑差異
|
| | | | | | | (18) | | | | | | − | | | | | | − | | |
不重新歸類為利潤的其他全面收入
或後續期間虧損(税後淨額): |
| | | | | | | | | | | | | | | | | | | | | |
貨幣折算成提示貨幣的匯兑差額
|
| | | | | | | 413 | | | | | | 2 | | | | | | (15) | | |
本年度其他綜合虧損,税後淨額
|
| | | | | | $ | 395 | | | | | $ | 2 | | | | | $ | (15) | | |
全面虧損
|
| | | | | | $ | (14,623) | | | | | $ | (11,193) | | | | | $ | (5,550) | | |
Evaxion股東應佔全面虧損總額
Biotech A/S |
| | | | | | $ | (14,623) | | | | | $ | (11,193) | | | | | $ | (5,550) | | |
Loss per share – basic and diluted
|
| |
11
|
| | | $ | (0.97) | | | | | $ | (0.81) | | | | | $ | (0.43) | | |
| | | | | |
December 31,
|
| |||||||||
| | |
Note
|
| |
2020
|
| |
2019
|
| ||||||
| | | | | |
(USD in thousands)
|
| |||||||||
ASSETS | | | | | | | | | | | | | | | | |
Non-current assets | | | | | | | | | | | | | | | | |
Intangible assets
|
| |
12
|
| | | $ | 100 | | | | | $ | − | | |
Deferred tax assets
|
| |
10
|
| | | | 262 | | | | | | − | | |
財產和設備,淨額
|
| |
13
|
| | | | 221 | | | | | | 101 | | |
政府撥款應收賬款
|
| | | | | | | 194 | | | | | | − | | |
Leasehold deposits
|
| |
17
|
| | | | 238 | | | | | | 25 | | |
非流動資產合計
|
| | | | | | | 1,015 | | | | | | 126 | | |
Current assets | | | | | | | | | | | | | | | | |
預付款和其他應收款
|
| |
14
|
| | | | 1,971 | | | | | | 575 | | |
延期發售成本
|
| |
1
|
| | | | 1,729 | | | | | | − | | |
Tax receivables
|
| | | | | | | 1,416 | | | | | | 824 | | |
現金和現金等價物
|
| |
16
|
| | | | 5,834 | | | | | | 9,559 | | |
Total current assets
|
| | | | | | | 10,950 | | | | | | 10,958 | | |
TOTAL ASSETS
|
| | | | | | $ | 11,965 | | | | | $ | 11,084 | | |
權益和負債 | | | | | | | | | | | | | | | | |
Share capital
|
| |
18
|
| | | $ | 2,648 | | | | | $ | 2,481 | | |
Other reserves
|
| |
18
|
| | | | 31,669 | | | | | | 22,693 | | |
Accumulated deficit
|
| |
18
|
| | | | (27,279) | | | | | | (15,812) | | |
Total equity
|
| | | | | | | 7,038 | | | | | | 9,362 | | |
流動負債 | | | | | | | | | | | | | | | | |
Lease liabilities
|
| |
17
|
| | | | 20 | | | | | | 36 | | |
Trade payables
|
| | | | | | | 2,646 | | | | | | 646 | | |
Other payables
|
| |
15
|
| | | | 2,261 | | | | | | 1,040 | | |
流動負債總額
|
| | | | | | | 4,927 | | | | | | 1,722 | | |
Total liabilities
|
| | | | | | | 4,927 | | | | | | 1,722 | | |
權益和負債合計
|
| | | | | | $ | 11,965 | | | | | $ | 11,084 | | |
| | | | | | | | | | | |
Other reserves
|
| | | | | | | | | | | | | |||||||||
| | |
Note
|
| |
Share capital
|
| |
Share
premium |
| |
Foreign
currency translation reserve |
| |
Accumulated
deficit |
| |
Total equity
|
| |||||||||||||||
| | | | | |
(USD in thousands)
|
| |||||||||||||||||||||||||||
Equity at January 1, 2018
|
| | | | | | $ | 117 | | | | | $ | 6,102 | | | | | $ | (156) | | | | | | (3,513) | | | | | $ | 2,550 | | |
Bonus share issuance
|
| |
23
|
| | | | 1,996 | | | | | | (1,996) | | | | | | − | | | | | | − | | | | | | − | | |
Equity at January 1, 2018
|
| | | | | | $ | 2,113 | | | | | $ | 4,106 | | | | | $ | (156) | | | | | $ | (3,513) | | | | | $ | 2,550 | | |
Net loss for the year
|
| | | | | | | − | | | | | | − | | | | | | − | | | | | | (5,535) | | | | | | (5,535) | | |
其他綜合收益
|
| | | | | | | − | | | | | | − | | | | | | (15) | | | | | | − | | | | | | (15) | | |
基於股份的薪酬
|
| |
9
|
| | | | − | | | | | | − | | | | | | − | | | | | | 2,069 | | | | | | 2,069 | | |
Equity at December 31, 2018
|
| | | | | | $ | 2,113 | | | | | $ | 4,106 | | | | | $ | (171) | | | | | $ | (6,979) | | | | | $ | (931) | | |
Net loss for the year
|
| | | | | | | − | | | | | | − | | | | | | − | | | | | | (11,195) | | | | | | (11,195) | | |
其他綜合收益
|
| | | | | | | − | | | | | | − | | | | | | 2 | | | | | | − | | | | | | 2 | | |
基於股份的薪酬
|
| |
8
|
| | | | − | | | | | | − | | | | | | − | | | | | | 2,362 | | | | | | 2,362 | | |
發行股票換取現金
|
| |
18
|
| | | | 181 | | | | | | 9,261 | | | | | | − | | | | | | − | | | | | | 9,442 | | |
Transaction costs
|
| |
18
|
| | | | − | | | | | | (13) | | | | | | − | | | | | | − | | | | | | (13) | | |
可轉換債務工具結算
|
| |
20
|
| | | | 187 | | | | | | 9,508 | | | | | | − | | | | | | − | | | | | | 9,695 | | |
Equity at December 31, 2019
|
| | | | | | $ | 2,481 | | | | | $ | 22,862 | | | | | $ | (169) | | | | | $ | (15,812) | | | | | $ | 9,362 | | |
Net loss for the year
|
| | | | | | | − | | | | | | − | | | | | | − | | | | | | (15,018) | | | | | | (15,018) | | |
其他綜合收益
|
| | | | | | | − | | | | | | − | | | | | | 395 | | | | | | − | | | | | | 395 | | |
基於股份的薪酬
|
| |
8
|
| | | | − | | | | | | − | | | | | | − | | | | | | 3,551 | | | | | | 3,551 | | |
發行股票換取現金
|
| |
18
|
| | | | 167 | | | | | | 8,853 | | | | | | − | | | | | | − | | | | | | 9,020 | | |
Transaction costs
|
| |
18
|
| | | | − | | | | | | (272) | | | | | | − | | | | | | − | | | | | | (272) | | |
Equity at December 31, 2020
|
| | | | | | $ | 2,648 | | | | | $ | 31,443 | | | | | $ | 226 | | | | | $ | (27,279) | | | | | $ | 7,038 | | |
| | |
Note
|
| |
Years Ended December 31,
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| ||||||||||||
| | | | | |
(USD in thousands)
|
| |||||||||||||||
經營活動: | | | | | | | | | | | | | | | | | | | | | | |
Net loss for the year
|
| | | | | | $ | (15,018) | | | | | $ | (11,195) | | | | | $ | (5,535) | | |
非現金項目調整
|
| |
16
|
| | | | 1,583 | | | | | | 2,945 | | | | | | 2,123 | | |
Interest received
|
| | | | | | | − | | | | | | 9 | | | | | | 2 | | |
Interest paid
|
| | | | | | | (30) | | | | | | (39) | | | | | | (15) | | |
Income taxes received
|
| | | | | | | 812 | | | | | | 688 | | | | | | 453 | | |
工作變更前的經營活動現金流
capital |
| | | | | | | (12,653) | | | | | | (7,592) | | | | | | (2,972) | | |
營運資金變動產生的現金流: | | | | | | | | | | | | | | | | | | | | | | |
淨營運資金變動
|
| |
16
|
| | | | 215 | | | | | | 573 | | | | | | 981 | | |
經營活動中使用的淨現金
|
| | | | | | | (12,438) | | | | | | (7,019) | | | | | | (1,991) | | |
投資活動: | | | | | | | | | | | | | | | | | | | | | | |
無形資產投資
|
| |
12
|
| | | | (35) | | | | | | − | | | | | | − | | |
購置房產、廠房和設備
|
| |
13
|
| | | | (149) | | | | | | (61) | | | | | | (7) | | |
支付非流動金融資產 - 租賃權
deposits |
| | | | | | | (209) | | | | | | (7) | | | | | | 13 | | |
投資活動淨額(現金使用)/提供
|
| | | | | | | (393) | | | | | | (68) | | | | | | 6 | | |
融資活動: | | | | | | | | | | | | | | | | | | | | | | |
股票發行收益
|
| |
18
|
| | | | 9,020 | | | | | | 9,442 | | | | | | 1,092 | | |
與發行股票相關的交易成本
|
| | | | | | | (128) | | | | | | (13) | | | | | | − | | |
發行可轉換債務工具所得收益
|
| |
16
|
| | | | − | | | | | | 152 | | | | | | 7,998 | | |
Leasing installments
|
| |
16,17
|
| | | | (74) | | | | | | (73) | | | | | | (63) | | |
融資活動提供的現金淨額
|
| | | | | | | 8,818 | | | | | | 9,508 | | | | | | 9,027 | | |
現金和現金等價物淨額(減少)/增加
|
| | | | | | | (4,013) | | | | | | 2,421 | | | | | | 7,042 | | |
1月1日的現金和現金等價物
|
| |
16
|
| | | | 9,559 | | | | | | 7,433 | | | | | | 468 | | |
現金和現金等價物的匯率調整
|
| | | | | | | 288 | | | | | | (295) | | | | | | (77) | | |
12月31日的現金和現金等價物
|
| |
16
|
| | | $ | 5,834 | | | | | $ | 9,559 | | | | | $ | 7,433 | | |
補充披露現金流量信息 | | | | | | | | | | | | | | | | | | | | | | |
非現金投融資活動 | | | | | | | | | | | | | | | | | | | | | | |
其他應付款中包含的資本化無形資產
|
| |
12
|
| | | | 60 | | | | | | − | | | | | | − | | |
Assets
|
| |
Useful life
|
|
Properties | | | 資產的租賃期限和使用壽命較短 | |
Other equipment | | | 3 – 6 years | |
| | |
December 31, 2020
|
| |||||||||||||||||||||||||||||||||
|
(USD in thousands)
|
| |||||||||||||||||||||||||||||||||||
|
Carrying
amount |
| |
Contractual
cash flows |
| |
|
| |
1 – 5 years
|
| |
>5 years
|
| |
Total
|
| ||||||||||||||||||||
Lease liabilities
|
| | | $ | 20 | | | | | $ | 20 | | | | | $ | 20 | | | | | $ | – | | | | | $ | – | | | | | $ | 20 | | |
Trade payables
|
| | | | 2,646 | | | | | | 2,646 | | | | | | 2,646 | | | | | | – | | | | | | – | | | | | | 2,646 | | |
Other payables
|
| | | | 180 | | | | | | 180 | | | | | | 180 | | | | | | – | | | | | | – | | | | | | 180 | | |
Total
|
| | | $ | 2,846 | | | | | $ | 2,846 | | | | | $ | 2,846 | | | | | $ | – | | | | | $ | – | | | | | $ | 2,846 | | |
| | |
December 31, 2019
|
| |||||||||||||||||||||||||||||||||
|
(USD in thousands)
|
| |||||||||||||||||||||||||||||||||||
|
Carrying
amount |
| |
Contractual
cash flows |
| |
|
| |
1 – 5 years
|
| |
>5 years
|
| |
Total
|
| ||||||||||||||||||||
Lease liabilities
|
| | | $ | 36 | | | | | $ | 55 | | | | | $ | 55 | | | | | $ | – | | | | | $ | – | | | | | $ | 55 | | |
Trade payables
|
| | | | 646 | | | | | | 646 | | | | | | 646 | | | | | | – | | | | | | – | | | | | | 646 | | |
Other payables
|
| | | | 177 | | | | | | 177 | | | | | | 177 | | | | | | – | | | | | | – | | | | | | 177 | | |
Total
|
| | | $ | 859 | | | | | $ | 878 | | | | | $ | 878 | | | | | $ | – | | | | | $ | – | | | | | $ | 878 | | |
| | |
Years Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
員工工資和福利支出,不包括基於股份的薪酬
|
| | | $ | (3,337) | | | | | $ | (2,586) | | | | | $ | (1,756) | | |
基於股份的薪酬費用
|
| | | | (1,496) | | | | | | (1,021) | | | | | | (896) | | |
Depreciation
|
| | | | (92) | | | | | | (65) | | | | | | (59) | | |
External expenses
|
| | | | (5,977) | | | | | | (4,544) | | | | | | (1,018) | | |
研發費用總額
|
| | | $ | (10,902) | | | | | $ | (8,216) | | | | | $ | (3,729) | | |
| | |
Years Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
員工工資和福利支出,不包括基於股份的薪酬
|
| | | $ | (1,098) | | | | | $ | (517) | | | | | $ | (190) | | |
基於股份的薪酬費用
|
| | | | (1,912) | | | | | | (1,341) | | | | | | (1,173) | | |
專業人員和其他費用
|
| | | | (2,644) | | | | | | (773) | | | | | | (520) | | |
Depreciation
|
| | | | (12) | | | | | | (16) | | | | | | (15) | | |
一般和行政費用合計
|
| | | $ | (5,666) | | | | | $ | (2,647) | | | | | $ | (1,898) | | |
| | |
Years Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
全職員工平均人數
|
| | | | 33 | | | | | | 25 | | | | | | 18 | | |
期末員工人數: | | | | | | | | | | | | | | | | | | | |
丹麥和美國
|
| | | | 35 | | | | | | 31 | | | | | | 20 | | |
期末員工總數
|
| | | | 35 | | | | | | 31 | | | | | | 20 | | |
| | |
Years Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
Wages and salaries
|
| | | $ | 4,016 | | | | | $ | 2,819 | | | | | $ | 1,733 | | |
基於股份的薪酬費用
|
| | | | 3,408 | | | | | | 2,362 | | | | | | 2,069 | | |
已定義的繳費計劃
|
| | | | 206 | | | | | | 96 | | | | | | 70 | | |
其他社會保障費用
|
| | | | 17 | | | | | | 12 | | | | | | 10 | | |
Other staff expenses
|
| | | | 196 | | | | | | 176 | | | | | | 133 | | |
Total
|
| | | $ | 7,843 | | | | | $ | 5,465 | | | | | $ | 4,015 | | |
| | |
Years Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
員工總成本分類為: | | | | | | | | | | | | | | | | | | | |
研發費用
|
| | | $ | 4,833 | | | | | $ | 3,607 | | | | | $ | 2,652 | | |
一般和行政費用
|
| | | | 3,010 | | | | | | 1,858 | | | | | | 1,363 | | |
Total
|
| | | $ | 7,843 | | | | | $ | 5,465 | | | | | $ | 4,015 | | |
| | |
Years Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
非管理層員工福利支出分類為: | | | | | | | | | | | | | | | | | | | |
研發費用
|
| | | $ | 4,009 | | | | | $ | 2,590 | | | | | $ | 1,686 | | |
一般和行政費用
|
| | | | 611 | | | | | | 668 | | | | | | 26 | | |
Total
|
| | | $ | 4,620 | | | | | $ | 3,258 | | | | | $ | 1,712 | | |
| | |
Year Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
高管薪酬: | | | | | | | | | | | | | | | | | | | |
Wages and salaries
|
| | | $ | 1,298 | | | | | $ | 900 | | | | | $ | 621 | | |
基於股份的薪酬費用
|
| | | | 1,566 | | | | | | 956 | | | | | | 1,157 | | |
Total
|
| | | | 2,864 | | | | | | 1,856 | | | | | | 1,778 | | |
董事會薪酬:
|
| | | | | | | | | | | | | | | | | | |
基於股份的薪酬費用
|
| | | | 359 | | | | | | 351 | | | | | | 525 | | |
Total
|
| | | | 359 | | | | | | 351 | | | | | | 525 | | |
董事會和執行管理層的薪酬分類為:
|
| | | | | | | | | | | | | | | | | | |
研發費用
|
| | | | 824 | | | | | | 1,017 | | | | | | 965 | | |
一般和行政費用
|
| | | | 2,399 | | | | | | 1,190 | | | | | | 1,338 | | |
Total
|
| | | $ | 3,223 | | | | | $ | 2,207 | | | | | $ | 2,303 | | |
| | |
Number of
warrants |
| |
Weighted
Average Exercise Price/Share (DKK) |
| |
Weighted
Average Remaining Contractual Life (years) |
| ||||||
Warrants granted as at January 1, 2018*
|
| | | | 1,481,796 | | | |
DKK 1
|
| | | | 19 | | |
Warrants granted**
|
| | | | 192,528 | | | |
1
|
| | | | 18 | | |
Warrants granted as at December 31, 2018
|
| | | | 1,674,324 | | | |
1
|
| | | | 18 | | |
Warrants granted**
|
| | | | 257,832 | | | |
1
|
| | | | 17 | | |
Warrants granted as at December 31, 2019
|
| | | | 1,932,156 | | | |
1
|
| | | | 17 | | |
Warrants granted
|
| | | | 363,168 | | | |
1
|
| | | | 11 | | |
Warrants forfeited
|
| | | | (45,216) | | | |
1
|
| | | | 16 | | |
Warrants cancelled
|
| | | | (22,032) | | | |
1
|
| | | | 16 | | |
Warrants granted as at December 31, 2020
|
| | | | 2,228,076 | | | |
DKK 1
|
| | | | 15 | | |
於2019年12月31日可行使的認股權證
|
| | | | – | | | |
–
|
| | | | – | | |
於2020年12月31日可行使的認股權證
|
| | | | – | | | |
–
|
| | | | – | | |
| | |
Years Ended
December 31, |
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
研發費用
|
| | | $ | 1,496 | | | | | $ | 1,021 | | | | | $ | 896 | | |
一般和行政費用
|
| | | | 1,912 | | | | | | 1,341 | | | | | | 1,173 | | |
Total
|
| | | $ | 3,408 | | | | | $ | 2,362 | | | | | $ | 2,069 | | |
Outstanding program
|
| |
Per warrant
grant date fair value (DKK) |
| |
Number of
warrants outstanding |
| |
Average
exercise price per warrant (DKK) |
| |
Remaining
term to maturity (years) |
| ||||||||||||
Grant (December 2016)
|
| | | | 20.91 | | | | | | 712,332 | | | | | | 1 | | | | | | 16 | | |
Grant (April 2017)
|
| | | | 24.05 | | | | | | 13,896 | | | | | | 1 | | | | | | 16 | | |
Grant (September 2017)
|
| | | | 28.71 | | | | | | 617,184 | | | | | | 1 | | | | | | 16 | | |
Grant (December 2017)
|
| | | | 28.71 | | | | | | 127,044 | | | | | | 1 | | | | | | 16 | | |
Grant (during 2018)
|
| | | | 37.05 | | | | | | 181,836 | | | | | | 1 | | | | | | 16 | | |
Grant (February 2019)
|
| | | | 42.57 | | | | | | 7,956 | | | | | | 1 | | | | | | 16 | | |
Grant (September 2019)
|
| | | | 56.35 | | | | | | 54,000 | | | | | | 1 | | | | | | 16 | | |
Grant (October 2019)
|
| | | | 56.97 | | | | | | 150,660 | | | | | | 1 | | | | | | 16 | | |
Grant (December 2020)
|
| | | | 56.75 | | | | | | 363,168 | | | | | | 1 | | | | | | 11 | | |
Granted at December 31, 2020
|
| | | | | | | | | | 2,228,076 | | | | | | 1 | | | | | | 15 | | |
可於2020年12月31日起執行的認股權證
|
| | | | | | | | | | – | | | | | | | | | | | | | | |
Outstanding program
|
| |
Per warrant
grant date fair value (DKK) |
| |
Number of
warrants outstanding |
| |
Average
exercise price per warrant (DKK) |
| |
Remaining
term to maturity (years) |
| ||||||||||||
Grant (December 2016)
|
| | | | 20.91 | | | | | | 712,332 | | | | | | 1 | | | | | | 17 | | |
Grant (April 2017)
|
| | | | 24.05 | | | | | | 13,896 | | | | | | 1 | | | | | | 17 | | |
Grant (September 2017)
|
| | | | 28.71 | | | | | | 617,184 | | | | | | 1 | | | | | | 17 | | |
Grant (December 2017)
|
| | | | 28.71 | | | | | | 138,384 | | | | | | 1 | | | | | | 17 | | |
Grant (during 2018)(1)**
|
| | | | 37.05 | | | | | | 192,528 | | | | | | 1 | | | | | | 17 | | |
Grant (January 2019)(1)**
|
| | | | 37.05 | | | | | | 45,216 | | | | | | 1 | | | | | | 17 | | |
Grant (February 2019)**
|
| | | | 42.57 | | | | | | 7,956 | | | | | | 1 | | | | | | 17 | | |
Grant (September 2019)**
|
| | | | 56.35 | | | | | | 54,000 | | | | | | 1 | | | | | | 17 | | |
Grant (October 2019)**
|
| | | | 56.97 | | | | | | 150,660 | | | | | | 1 | | | | | | 17 | | |
Granted at December 31, 2019
|
| | | | | | | | | | 1,932,156 | | | | | | 1 | | | | | | 17 | | |
可於2019年12月31日起行使的認股權證
|
| | | | | | | | | | – | | | | | | | | | | | | | | |
Outstanding program
|
| |
Per
warrant grant date fair value (DKK) |
| |
Average
Number of warrants outstanding |
| |
Remaining
exercise price per warrant (DKK) |
| |
term to
maturity (years) |
| ||||||||||||
Grant (December 2016)
|
| | | | 20.91 | | | | | | 712,332 | | | | | | 1 | | | | | | 18 | | |
Grant (April 2017)
|
| | | | 24.05 | | | | | | 13,896 | | | | | | 1 | | | | | | 18 | | |
Grant (September 2017)
|
| | | | 28.71 | | | | | | 617,184 | | | | | | 1 | | | | | | 18 | | |
Grant (December 2017)
|
| | | | 28.71 | | | | | | 138,384 | | | | | | 1 | | | | | | 18 | | |
Grant (during 2018)**
|
| | | | 37.05 | | | | | | 192,528 | | | | | | 1 | | | | | | 18 | | |
Granted at December 31, 2018
|
| | | | | | | | | | 1,674,324 | | | | | | 1 | | | | | | 18 | | |
可於2018年12月31日執行的認股權證
|
| | | | | | | | | | – | | | | | | | | | | | | | | |
Number of
warrants held |
| |
January 1,
2018 |
| |
Granted
|
| |
December 31,
2018 |
| |
Granted
|
| |
December 31,
2019 |
| |
Warrants held
when becoming or leaving as a member of management |
| |
Granted
|
| |
Forfeited
|
| |
December 31,
2020 |
| |||||||||||||||||||||||||||
Thomas William Wylonis(1)
|
| | | | 293,364 | | | | | | 49,248 | | | | | | 342,612 | | | | | | – | | | | | | 342,612 | | | | | | (369,252) | | | | | | 26,640 | | | | | | – | | | | | | – | | |
Steven Projan
|
| | | | – | | | | | | 23,436 | | | | | | 23,436 | | | | | | – | | | | | | 23,436 | | | | | | – | | | | | | 18,612 | | | | | | – | | | | | | 42,048 | | |
Roberto Prego
|
| | | | 7,416 | | | | | | 12,384 | | | | | | 19,800 | | | | | | – | | | | | | 19,800 | | | | | | – | | | | | | 14,364 | | | | | | – | | | | | | 34,164 | | |
Joann Suzich
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | 10,260 | | | | | | – | | | | | | 10,260 | | |
Marianne Søgaard(2)
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | 65,952 | | | | | | 28,368 | | | | | | – | | | | | | 94,320 | | |
Helen Boudreau(3)
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | 5,436 | | | | | | – | | | | | | 5,436 | | |
Kim Bjørnstrup (former)(4)
|
| | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | – | | | | | | (5,868) | | | | | | 5,868 | | | | | | – | | | | | | – | | |
董事會總數
|
| | | | 300,780 | | | | | | 85,068 | | | | | | 385,848 | | | | | | – | | | | | | 385,848 | | | | | | (309,168) | | | | | | 109,548 | | | | | | – | | | | | | 186,228 | | |
Lars Aage Staal Wegner
|
| | | | 840,528 | | | | | | 3,888 | | | | | | 844,416 | | | | | | – | | | | | | 844,416 | | | | | | – | | | | | | 7,668 | | | | | | – | | | | | | 852,084 | | |
Thomas Bogenrieder
(former)(5) |
| | | | 4,356 | | | | | | – | | | | | | 4,356 | | | | | | 45,216 | | | | | | 49,572 | | | | | | (4,356) | | | | | | – | | | | | | (45,216) | | | | | | – | | |
Glenn S. Vraniak(6)
|
| | | | – | | | | | | – | | | | | | – | | | | | | 150,660 | | | | | | 150,660 | | | | | | – | | | | | | – | | | | | | – | | | | | | 150,660 | | |
高管管理合計
|
| | | | 844,884 | | | | | | 3,888 | | | | | | 848,772 | | | | | | 195,876 | | | | | | 1,044,648 | | | | | | (4,356) | | | | | | 7,668 | | | | | | (45,216) | | | | | | 1,002,744 | | |
| | |
Year Ended
December 31, |
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
Financial income: | | | | | | | | | | | | | | | | | | | |
Interest income, bank
|
| | | $ | – | | | | | $ | 8 | | | | | $ | 2 | | |
Interest income, other
|
| | | | – | | | | | | 1 | | | | | | – | | |
Foreign exchange gains
|
| | | | 216 | | | | | | 56 | | | | | | 74 | | |
Total financial income
|
| | | | 216 | | | | | | 65 | | | | | | 76 | | |
Financial expenses: | | | | | | | | | | | | | | | | | | | |
Interest expenses
|
| | | | (29) | | | | | | (36)(10) | | | | | | | | |
可轉換債務工具公允價值變動
|
| | | | – | | | | | | (1,183) | | | | | | (684) | | |
利息支出、租賃負債
|
| | | | (3) | | | | | | (4) | | | | | | | | |
匯兑損失
|
| | | | (194) | | | | | | – | | | | | | (21) | | |
財務費用總額
|
| | | | (223) | | | | | | (1,222) | | | | | | (719) | | |
Net financial items
|
| | | $ | (7) | | | | | $ | (1,157) | | | | | $ | (643) | | |
| | |
Year Ended
December 31, |
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
所得税費用/(福利)
|
| | | $ | (1,557) | | | | | $ | (825) | | | | | $ | (735) | | |
本年度所得税總額
|
| | | $ | (1,557) | | | | | $ | (825) | | | | | $ | (735) | | |
| | |
Year Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
丹麥法定企業所得税税率
|
| | | | 22% | | | | | | 22% | | | | | | 22% | | |
不可扣除的收入/(費用)
|
| | | | (1)% | | | | | | (5)% | | | | | | (10)% | | |
免税收入/(費用)
|
| | | | 1% | | | | | | – | | | | | | – | | |
附加減税研發費用
|
| | | | 3% | | | | | | – | | | | | | – | | |
税收抵免研發支出
|
| | | | 9% | | | | | | 7% | | | | | | 12% | | |
未資本化的遞延税項資產變動
|
| | | | (25)% | | | | | | (17)% | | | | | | (12)% | | |
Total effective tax rate
|
| | | | 9% | | | | | | 7% | | | | | | 12% | | |
| | |
Year Ended
December 31, |
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||
遞延納税頭寸: | | | | | | | | | | | | | | | | | | | |
Warrants
|
| | | $ | 4,289 | | | | | $ | 3,034 | | | | | $ | 1,463 | | |
Loss carry forward
|
| | | | 3,759 | | | | | | 1,270 | | | | | | 136 | | |
研發支出
|
| | | | 262 | | | | | | – | | | | | | – | | |
Other items
|
| | | | (6) | | | | | | (34) | | | | | | 48 | | |
遞延税項資產計價準備
|
| | | | (8,042) | | | | | | (4,270) | | | | | | (1,647) | | |
Total capitalized
|
| | | $ | 262 | | | | | $ | – | | | | | $ | – | | |
| | |
Year Ended December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
| | |
(美元以千為單位,不包括股份金額
and per share amounts) |
| |||||||||||||||
稀釋前後每股虧損 | | | | | | | | | | | | | | | | | | | |
Evaxion Biotech A/S股東應佔淨虧損
|
| | | $ | (15,018) | | | | | $ | (11,195) | | | | | $ | (5,535) | | |
加權平均普通股數量
outstanding |
| | | | 15,434,758 | | | | | | 13,892,314 | | | | | | 12,917,016 | | |
稀釋前後每股虧損
|
| | | $ | (0.97) | | | | | $ | (0.81) | | | | | $ | (0.43) | | |
| | |
December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
Warrants
|
| | | | 2,228,076 | | | | | | 2,059,128 | | | | | | 1,674,324 | | |
Convertible Debt l
|
| | | | – | | | | | | – | | | | | | 302,976 | | |
Convertible Debt 2
|
| | | | – | | | | | | – | | | | | | 827,856 | | |
| | |
Intangible
Assets |
| |
Total
|
| ||||||
|
(USD in thousands)
|
| |||||||||||
Cost at December 31, 2019
|
| | | $ | – | | | | | $ | – | | |
本年度新增數量
|
| | | | 95 | | | | | | 95 | | |
匯率調整
|
| | | | 5 | | | | | | 5 | | |
Cost at December 31, 2020
|
| | | | 100 | | | | | | 100 | | |
Amortization at December 31, 2019
|
| | | | – | | | | | | – | | |
本年度攤銷
|
| | | | – | | | | | | – | | |
匯率調整
|
| | | | – | | | | | | – | | |
Amortization at December 31, 2020
|
| | | | – | | | | | | – | | |
Carrying amount at December 31, 2020
|
| | | $ | 100 | | | | | $ | 100 | | |
| | |
Property
|
| |
Other
Equipment |
| |
Total
|
| |||||||||
|
(USD in thousands)
|
| |||||||||||||||||
Cost at December 31, 2019
|
| | | $ | 179 | | | | | $ | 93 | | | | | $ | 272 | | |
本年度新增數量
|
| | | | 55 | | | | | | 149 | | | | | | 204 | | |
匯率調整
|
| | | | 23 | | | | | | 21 | | | | | | 44 | | |
Cost at December 31, 2020
|
| | | | 257 | | | | | | 263 | | | | | | 520 | | |
Depreciation at December 31, 2019
|
| | | | (144) | | | | | | (27) | | | | | | (171) | | |
本年度折舊
|
| | | | (71) | | | | | | (34) | | | | | | (105) | | |
匯率調整
|
| | | | (22) | | | | | | (1) | | | | | | (23) | | |
Depreciation at December 31, 2020
|
| | | | (237) | | | | | | (64) | | | | | | (299) | | |
Carrying amount at December 31, 2020
|
| | | $ | 20 | | | | | $ | 201 | | | | | $ | 221 | | |
2020年12月31日使用權資產賬面金額
|
| | | $ | 20 | | | | | $ | – | | | | | $ | 20 | | |
| | |
Property
|
| |
Other
Equipment |
| |
Total
|
| |||||||||
|
(USD in thousands)
|
| |||||||||||||||||
Cost at January 1, 2019
|
| | | $ | 171 | | | | | $ | 32 | | | | | $ | 203 | | |
本年度新增數量
|
| | | | 12 | | | | | | 61 | | | | | | 73 | | |
匯率調整
|
| | | | (4) | | | | | | – | | | | | | (4) | | |
Cost at December 31, 2019
|
| | | | 179 | | | | | | 93 | | | | | | 272 | | |
Depreciation at January 1, 2019
|
| | | | (79) | | | | | | (13) | | | | | | (92) | | |
本年度折舊
|
| | | | (67) | | | | | | (14) | | | | | | (81) | | |
匯率調整
|
| | | | 2 | | | | | | – | | | | | | 2 | | |
Depreciation at December 31, 2019
|
| | | | (144) | | | | | | (27) | | | | | | (171) | | |
Carrying amount at December 31, 2019
|
| | | $ | 35 | | | | | $ | 66 | | | | | $ | 101 | | |
2019年12月31日使用權資產賬面金額
|
| | | $ | 35 | | | | | $ | – | | | | | $ | 35 | | |
| | |
Year Ended
December 31, |
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
|
(USD in thousands)
|
| |||||||||||||||||
研發
|
| | | $ | 90 | | | | | $ | 64 | | | | | $ | 58 | | |
一般和行政
|
| | | | 15 | | | | | | 16 | | | | | | 15 | | |
全面損失表中包含的折舊總額
|
| | | $ | 105 | | | | | $ | 80 | | | | | $ | 73 | | |
12月31日使用權資產累計折舊總額
|
| | | $ | 236 | | | | | $ | 145 | | | | | $ | 79 | | |
| | |
December 31,
|
| |||||||||
|
2020
|
| |
2019
|
| ||||||||
|
(USD in thousands)
|
| |||||||||||
VAT receivables
|
| | | $ | 376 | | | | | $ | 75 | | |
Prepayments
|
| | | | 1,175 | | | | | | 451 | | |
向臨牀研究機構預付款項
|
| | | | 418 | | | | | | 17 | | |
Other receivables
|
| | | | 2 | | | | | | 32 | | |
預付款和其他應收款合計
|
| | | $ | 1,971 | | | | | $ | 575 | | |
| | |
December 31,
|
| |||||||||
|
2020
|
| |
2019
|
| ||||||||
|
(USD in thousands)
|
| |||||||||||
支付給臨牀研究機構的款項
|
| | | $ | 1,027 | | | | | $ | 588 | | |
員工成本負債
|
| | | | 1,054 | | | | | | 275 | | |
Other liabilities
|
| | | | 180 | | | | | | 177 | | |
Total other payables
|
| | | $ | 2,261 | | | | | $ | 1,040 | | |
| | |
December 31,
|
| |||||||||
|
2020
|
| |
2019
|
| ||||||||
|
(USD in thousands)
|
| |||||||||||
現金和現金等價物
|
| | | $ | 5,834 | | | | | $ | 9,559 | | |
現金和現金等價物合計
|
| | | $ | 5,834 | | | | | $ | 9,559 | | |
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
|
(USD in thousands)
|
| |||||||||||||||||
應收賬款和應收税金的變動
|
| | | $ | (2,501) | | | | | $ | (337) | | | | | $ | 443 | | |
貿易應付款變更
|
| | | | 1,798 | | | | | | 507 | | | | | | 79 | | |
其他應付款的更改
|
| | | | 918 | | | | | | 403 | | | | | | 459 | | |
淨營運資金變動
|
| | | $ | 215 | | | | | $ | 573 | | | | | $ | 981 | | |
| | |
Year Ended
December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
|
(USD in thousands)
|
| |||||||||||||||||
Income taxes
|
| | | $ | (1,557) | | | | | $ | (825) | | | | | $ | (735) | | |
税收抵免方案作為贈款入賬
|
| | | | (510) | | | | | | – | | | | | | – | | |
折舊及攤銷
|
| | | | 105 | | | | | | 81 | | | | | | 74 | | |
Interest income
|
| | | | – | | | | | | (9) | | | | | | (2) | | |
Interest expense
|
| | | | 30 | | | | | | 39 | | | | | | 15 | | |
基於股份的薪酬費用
|
| | | | 3,408 | | | | | | 2,362 | | | | | | 2,069 | | |
可轉換債務工具公允價值變動
|
| | | | – | | | | | | 1,183 | | | | | | 684 | | |
其他調整:其他調整,主要是匯率調整
|
| | | | 107 | | | | | | 114 | | | | | | 18 | | |
非現金項目調整合計
|
| | | $ | 1,583 | | | | | $ | 2,945 | | | | | $ | 2,123 | | |
(USD in thousands)
|
| |
December 31,
2019 |
| |
Cash flows
|
| |
Accumulated
interest |
| |
Additions
|
| |
Exchange rate
adjustment |
| |
December 31,
2020 |
| ||||||||||||||||||
Lease liabilities
|
| | | $ | 36 | | | | | $ | (74) | | | | | $ | 1 | | | | | $ | 54 | | | | | $ | 3 | | | | | $ | 20 | | |
融資活動的總負債
|
| | | $ | 36 | | | | | $ | (74) | | | | | $ | 1 | | | | | $ | 54 | | | | | $ | 3 | | | | | $ | 20 | | |
(USD in thousands)
|
| |
December 31,
2018 |
| |
Cash flows
|
| |
Accumulated
interest |
| |
Fair value
adjustment |
| |
Additions
|
| |
Conversion
|
| |
Exchange rate
adjustment |
| |
December 31,
2019 |
| ||||||||||||||||||||||||
Lease liabilities
|
| | | $ | 99 | | | | | $ | (75) | | | | | $ | 2 | | | | | $ | – | | | | | $ | 12 | | | | | $ | – | | | | | $ | (2) | | | | | $ | 36 | | |
可轉換債務工具
|
| | | | 8,569 | | | | | | 152 | | | | | | – | | | | | | 1,183 | | | | | | – | | | | | | (9,695) | | | | | | (209) | | | | | | – | | |
融資活動的總負債
|
| | | $ | 8,668 | | | | | $ | 77 | | | | | $ | 2 | | | | | $ | 1,183 | | | | | $ | 12 | | | | | $ | (9,695) | | | | | $ | (211) | | | | | $ | 36 | | |
| | |
Right-of-Use Asset
|
| |
Lease liabilities
|
| ||||||
|
(USD in thousands)
|
| |||||||||||
At December 31, 2019
|
| | | $ | 35 | | | | | $ | 36 | | |
Additions
|
| | | | 54 | | | | | | 54 | | |
Depreciation
|
| | | | (73) | | | | | | – | | |
Interest Expense
|
| | | | – | | | | | | – | | |
Payments
|
| | | | 4 | | | | | | (74) | | |
Translation
|
| | | | – | | | | | | 4 | | |
At December 31, 2020
|
| | | $ | 20 | | | | | $ | 20 | | |
| | |
Right-of-Use Asset
|
| |
Lease liabilities
|
| ||||||
|
(USD in thousands)
|
| |||||||||||
At January 1, 2019
|
| | | $ | 92 | | | | | $ | 99 | | |
Additions
|
| | | | 12 | | | | | | 12 | | |
Depreciation
|
| | | | (67) | | | | | | – | | |
Interest Expense
|
| | | | – | | | | | | 2 | | |
Payments
|
| | | | – | | | | | | (75) | | |
Translation
|
| | | | (2) | | | | | | (2) | | |
At December 31, 2019
|
| | | $ | 35 | | | | | $ | 36 | | |
| | |
Number of
Ordinary Shares |
| |
Share Capital
(DKK in thousands) |
| ||||||
Share capital, January 1, 2018
|
| | | | 12,917,016 | | | | | | 12,917 | | |
Share capital, December 31, 2018
|
| | | | 12,917,016 | | | | | | 12,917 | | |
2019年7月17日增資(發行股票換現金)
|
| | | | 997,668 | | | | | | 998 | | |
2019年7月17日增資(可轉債轉換1)
|
| | | | 302,976 | | | | | | 303 | | |
2019年7月17日增資(可轉債轉換2)
|
| | | | 848,232 | | | | | | 848 | | |
2019年12月19日增資(發行股票換現金)
|
| | | | 118,260 | | | | | | 118 | | |
Share capital, December 31, 2019
|
| | | | 15,184,152 | | | | | | 15,184 | | |
2020年9月17日增資(發行股票換現金)
|
| | | | 745,380 | | | | | | 745 | | |
2020年10月15日增資(發行股票換現金)
|
| | | | 269,136 | | | | | | 269 | | |
Share capital, December 31, 2020
|
| | | | 16,198,668 | | | | | | 16,198 | | |
| | |
December 31,
|
| |||||||||
|
2020
|
| |
2019
|
| ||||||||
|
(USD in thousands)
|
| |||||||||||
授權、簽發和全額支付
|
| | | | | | | | | | | | |
16,198,668 (2019:15,184,152) ordinary shares of DKK 1 each (2019: ordinary shares
of DKK 1 each) |
| | | $ | 2,648 | | | | | $ | 2,481 | | |
| | | | $ | 2,648 | | | | | $ | 2,481 | | |
擁有的普通股數量
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
Niels Iversen Møller
|
| | | | 4,292,604 | | | | | | 4,292,604 | | | | | | 4,292,352 | | |
Andreas Holm Mattsson
|
| | | | 4,163,832 | | | | | | 4,163,832 | | | | | | 4,163,832 | | |
Lars Aage Staal Wegner
|
| | | | 182,124 | | | | | | 182,124 | | | | | | 181,872 | | |
高管管理合計
|
| | | | 8,638,560 | | | | | | 8,638,560 | | | | | | 8,638,056 | | |
擁有的普通股數量
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
Roberto Prego
|
| | | | 676,620 | | | | | | 310,248 | | | | | | 307,548 | | |
Thomas William Wylonis
|
| | | | 485,676 | | | | | | 481,860 | | | | | | 471,096 | | |
Marianne Søgaard
|
| | | | 41,652 | | | | | | – | | | | | | – | | |
Steven Projan
|
| | | | 27,288 | | | | | | 11,736 | | | | | | – | | |
董事會總數
|
| | | | 1,231,236 | | | | | | 803,844 | | | | | | 778,644 | | |
| | |
Convertible loans
|
| | |||||
|
(USD in thousands)
|
| | |||||||
Carrying amount at January 1, 2018
|
| | | $ | – | | | | ||
Amount received in 2018
|
| | | | 7,998 | | | | ||
計入財務費用的公允價值調整
|
| | | | 684 | | | | ||
Currency adjustment
|
| | | | (113) | | | | ||
Carrying amount at December 31, 2018
|
| | | | 8,569 | | | | ||
Amount received in 2019
|
| | | | 152 | | | | ||
計入財務費用的公允價值調整
|
| | | | 1,183 | | | | ||
Currency adjustment
|
| | | | (209) | | | | ||
Converted to equity during 2019
|
| | | | (9,695) | | | | ||
Carrying amount at December 31, 2019
|
| | | $ | – | | | | ||
| | | | | | | | | | |
| | |
Assumption
applied |
|
DKK/USD exchange rate
|
| |
0.154
|
|
Discount rate
|
| |
Convertible Debt 1 – 39%
|
|
| | |
Convertible Debt 2 – 25%
|
|
符合條件的融資事件發生的概率
|
| |
95%
|
|
Evaxion share price
|
| |
$207
|
|
| | |
Impact on
Convertible Debt 1 |
| |
Impact on
Convertible Debt 2 |
| ||||||
|
(USD in thousands)
|
| |||||||||||
Exchange rate increased by 5%
|
| | | $ | (48) | | | | | $ | (272) | | |
Exchange rate decreased by 5%
|
| | | $ | 48 | | | | | $ | 272 | | |
Discount rate decreased by 3%
|
| | | $ | (24) | | | | | $ | (85) | | |
融資事件概率降低25%
|
| | | $ | (100) | | | | | $ | (40) | | |
Share price increased by 10%
|
| | | $ | (10) | | | | | $ | (39) | | |
Share price decreased by 10%
|
| | | $ | 10 | | | | | $ | 39 | | |
| | |
December 31,
|
| |||||||||||||||
|
2020
|
| |
2019
|
| |
2018
|
| |||||||||||
|
(USD in thousands)
|
| |||||||||||||||||
公司與其他關聯方的交易: | | | | | | | | | | | | | | | | | | | |
關聯方交易(費用):
|
| | | | | | | | | | | | | | | | | | |
發行給高管成員的可轉換債務工具的應計利息
管理層和董事會 |
| | | $ | – | | | | | $ | (4) | | | | | $ | (4) | | |
年末關聯方餘額(資產): | | | | | | | | | | | | | | | | | | | |
從關聯方處預付租賃物業的租金和押金
|
| | | $ | 7 | | | | | $ | – | | | | | $ | – | | |
年末關聯方餘額(負債): | | | | | | | | | | | | | | | | | | | |
向執行管理層和董事會成員發行的可轉換債務工具(名義價值外加7.5%的應計利息)
|
| | | $ | – | | | | | $ | – | | | | | $ | 117 | | |
| | |
December 31, 2020
|
| |||||||||||||||||||||||||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||||||||||||||||||||
| | |
Contractual
cash flows |
| |
|
| |
1 – 2 years
|
| |
2 – 5 years
|
| |
>5 years
|
| |
Total
|
| ||||||||||||||||||
Purchase obligations
|
| | | $ | 712 | | | | | $ | 712 | | | | | $ | – | | | | | $ | – | | | | | $ | – | | | | | $ | 712 | | |
Total
|
| | | $ | 712 | | | | | $ | 712 | | | | | $ | – | | | | | $ | – | | | | | $ | – | | | | | $ | 712 | | |
| | |
December 31,
|
| |||||||||
|
2020
|
| |
2019
|
| ||||||||
|
(USD in thousands)
|
| |||||||||||
Audit fees
|
| | | $ | 308 | | | | | $ | 73 | | |
Audit related fees
|
| | | | 119 | | | | | | – | | |
Other fees
|
| | | | 253 | | | | | | – | | |
Total fees
|
| | | $ | 680 | | | | | $ | 73 | | |
| | |
Three Months Ended
June 30, |
| |
Six Months Ended
June 30, |
| ||||||||||||||||||
| | |
2020
|
| |
2021
|
| |
2020
|
| |
2021
|
| ||||||||||||
| | |
(單位為千美元,每股除外)
|
| |||||||||||||||||||||
Operating expenses: | | | | | | ||||||||||||||||||||
研發
|
| | | $ | 2,570 | | | | | $ | 5,111 | | | | | $ | 5,080 | | | | | $ | 9,004 | | |
一般和行政
|
| | | | 1,372 | | | | | | 1,915 | | | | | | 2,153 | | | | | | 3,197 | | |
總運營費用
|
| | | | 3,942 | | | | | | 7,026 | | | | | | 7,233 | | | | | | 12,201 | | |
Operating loss
|
| | | | (3,942) | | | | | | (7,026) | | | | | | (7,233) | | | | | | (12,201) | | |
Finance income
|
| | | | 6 | | | | | | 33 | | | | | | 22 | | | | | | 1,005 | | |
Finance expenses
|
| | | | — | | | | | | (495) | | | | | | (4) | | | | | | (792) | | |
Net loss before tax
|
| | | | (3,936) | | | | | | (7,488) | | | | | | (7,215) | | | | | | (11,988) | | |
Income tax benefit
|
| | | | 296 | | | | | | 669 | | | | | | 476 | | | | | | 1,076 | | |
Net loss for the period
|
| | | $ | (3,640) | | | | | $ | (6,819) | | | | | $ | (6,739) | | | | | $ | (10,912) | | |
Evaxion Biotech A/S股東應佔淨虧損
|
| | | $ | (3,640) | | | | | $ | (6,819) | | | | | $ | (6,739) | | | | | $ | (10,912) | | |
後續期間可能重新分類為損益的其他全面收益:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
對外業務翻譯匯兑差異
|
| | | | (10) | | | | | | (57) | | | | | | (10) | | | | | | (28) | | |
其他綜合所得徵税
|
| | | | — | | | | | | 6 | | | | | | — | | | | | | — | | |
後續期間不重新計入損益的其他全面收益:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
貨幣折算成提示貨幣的匯兑差額
|
| | | | 109 | | | | | | 474 | | | | | | (71) | | | | | | (284) | | |
當期其他綜合虧損,税後淨額
|
| | | $ | 99 | | | | | $ | 423 | | | | | $ | (81) | | | | | $ | (312) | | |
全面虧損
|
| | | $ | (3,541) | | | | | $ | (6,396) | | | | | $ | (6,820) | | | | | $ | (11,224) | | |
Evaxion股東應佔全面虧損總額
Biotech A/S |
| | | $ | (3,541) | | | | | $ | (6,396) | | | | | $ | (6,820) | | | | | $ | (11,224) | | |
Loss per share – basic and diluted
|
| | | $ | (0.24) | | | | | $ | (0.36) | | | | | $ | (0.44) | | | | | $ | (0.59) | | |
| | |
Note
|
| |
December 31,
2020 |
| |
June 30,
2021 |
| |||||||||
| | | | | | | | |
(USD in thousands)
|
| |||||||||
ASSETS | | | | | | | | | | | | | | | | | | | |
Non-current assets | | | | | | | | | | | | | | | | | | | |
Intangible assets
|
| | | | | | | | | $ | 100 | | | | | $ | 97 | | |
Deferred tax assets
|
| | | | | | | | | | 262 | | | | | | 252 | | |
Property and equipment
|
| | |
|
2
|
| | | | | 221 | | | | | | 2,076 | | |
應收政府補助金
|
| | | | | | | | | | 194 | | | | | | 549 | | |
Tax receivables
|
| | | | | | | | | | — | | | | | | 1,058 | | |
Leasehold deposits
|
| | | | | | | | | | 238 | | | | | | 200 | | |
非流動資產合計 | | | | | | | | | | | 1,015 | | | | | | 4,232 | | |
Current assets | | | | | | | | | | | | | | | | | | | |
預付款和其他應收款
|
| | | | | | | | | | 1,553 | | | | | | 2,564 | | |
延期發售成本
|
| | | | | | | | | | 1,729 | | | | | | 265 | | |
應收政府補助金
|
| | | | | | | | | | 418 | | | | | | 421 | | |
Tax receivables
|
| | | | | | | | | | 1,416 | | | | | | 1,376 | | |
現金和現金等價物
|
| | | | | | | | | | 5,834 | | | | | | 18,799 | | |
Total current assets
|
| | | | | | | | | | 10,950 | | | | | | 23,425 | | |
TOTAL ASSETS
|
| | | | | | | | | $ | 11,965 | | | | | $ | 27,657 | | |
權益和負債 | | | | | | | | | | | | | | | | | | | |
Share capital
|
| | |
|
6
|
| | | | $ | 2,648 | | | | | $ | 3,132 | | |
Other reserves
|
| | | | | | | | | | 31,669 | | | | | | 56,168 | | |
Accumulated deficit
|
| | | | | | | | | | (27,279) | | | | | | (37,471) | | |
Total equity
|
| | | | | | | | | | 7,038 | | | | | | 21,829 | | |
非流動負債 | | | | | | | | | | | | | | | | | | | |
Lease liabilities
|
| | | | | | | | | | — | | | | | | 974 | | |
Provisions
|
| | | | | | | | | | — | | | | | | 53 | | |
非流動負債合計
|
| | | | | | | | | | — | | | | | | 1,027 | | |
流動負債 | | | | | | | | | | | | | | | | | | | |
Lease liabilities
|
| | | | | | | | | | 20 | | | | | | 136 | | |
Trade payables
|
| | | | | | | | | | 2,646 | | | | | | 1,552 | | |
Other payables
|
| | | | | | | | | | 2,261 | | | | | | 3,113 | | |
流動負債總額
|
| | | | | | | | | | 4,927 | | | | | | 4,801 | | |
Total liabilities
|
| | | | | | | | | | 4,927 | | | | | | 5,828 | | |
權益和負債合計
|
| | | | | | | | | $ | 11,965 | | | | | $ | 27,657 | | |
| | | | | | | | | | | | | | | | | | | | |
Other reserves
|
| | | |||||||||||||
| | |
Note
|
| |
Share
capital |
| |
Share
premium |
| |
Foreign
currency translation reserve |
| |
Accumulated
Deficit |
| |
Total
equity |
| ||||||||||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||||||||||||||||||||
Equity at December 31, 2019
|
| | | | | | | | | $ | 2,481 | | | | | $ | 22,862 | | | | | $ | (169) | | | | | $ | (15,812) | | | | | $ | 9,362 | | |
Net loss for the period
|
| | | | | | | | | | — | | | | | | — | | | | | | — | | | | | | (3,099) | | | | | | (3,099) | | |
其他綜合收益
|
| | | | | | | | | | — | | | | | | — | | | | | | (180) | | | | | | — | | | | | | (180) | | |
基於股份的薪酬
|
| | |
|
5
|
| | | | | — | | | | | | — | | | | | | — | | | | | | 680 | | | | | | 680 | | |
Equity at March 31, 2020
|
| | | | | | | | | $ | 2,481 | | | | | $ | 22,862 | | | | | $ | (349) | | | | | $ | (18,231) | | | | | $ | 6,763 | | |
Net loss for the period
|
| | | | | | | | | | — | | | | | | — | | | | | | — | | | | | | (3,640) | | | | | | (3,640) | | |
其他綜合收益
|
| | | | | | | | | | — | | | | | | — | | | | | | 99 | | | | | | — | | | | | | 99 | | |
基於股份的薪酬
|
| | |
|
5
|
| | | | | — | | | | | | — | | | | | | — | | | | | | 495 | | | | | | 495 | | |
Equity at June 30, 2020
|
| | | | | | | | | $ | 2,481 | | | | | $ | 22,862 | | | | | $ | (250) | | | | | $ | (21,376) | | | | | $ | 3,717 | | |
| | | | | | | | | | | | | | | | | | | | |
Other reserves
|
| | | | | | | | | | | | | |||
| | |
Note
|
| |
Share
capital |
| |
Share
premium |
| |
Foreign
currency translation reserve |
| |
Accumulated
Deficit |
| |
Total
equity |
| ||||||||||||||||||
| | |
(USD in thousands)
|
| |||||||||||||||||||||||||||||||||
Equity at December 31, 2020
|
| | | | | | | | | $ | 2,648 | | | | | $ | 31,443 | | | | | $ | 226 | | | | | $ | (27,279) | | | | | $ | 7,038 | | |
Net loss for the period
|
| | | | | | | | | | — | | | | | | — | | | | | | — | | | | | | (4,093) | | | | | | (4,093) | | |
其他綜合收益
|
| | | | | | | | | | — | | | | | | — | | | | | | (729) | | | | | | — | | | | | | (729) | | |
税收對其他綜合收益的影響
|
| | | | | | | | | | — | | | | | | — | | | | | | (6) | | | | | | — | | | | | | (6) | | |
基於股份的薪酬
|
| | |
|
5
|
| | | | | — | | | | | | — | | | | | | — | | | | | | 294 | | | | | | 294 | | |
發行股票換取現金
|
| | | | | | | | | | 484 | | | | | | 29,516 | | | | | | — | | | | | | — | | | | | | 30,000 | | |
Transaction costs
|
| | | | | | | | | | — | | | | | | (4,705) | | | | | | — | | | | | | — | | | | | | (4,705) | | |
Equity at March 31, 2021
|
| | | | | | | | | $ | 3,132 | | | | | $ | 56,254 | | | | | $ | (509) | | | | | $ | (31,078) | | | | | $ | 27,799 | | |
Net loss for the period
|
| | | | | | | | | | — | | | | | | — | | | | | | — | | | | | | (6,819) | | | | | | (6,819) | | |
其他綜合收益
|
| | | | | | | | | | — | | | | | | — | | | | | | 417 | | | | | | — | | | | | | 417 | | |
税收對其他綜合收益的影響
|
| | | | | | | | | | — | | | | | | — | | | | | | 6 | | | | | | — | | | | | | 6 | | |
基於股份的薪酬
|
| | |
|
5
|
| | | | | — | | | | | | — | | | | | | — | | | | | | 426 | | | | | | 426 | | |
Equity at June 30, 2021
|
| | | | | | | | | $ | 3,132 | | | | | $ | 56,254 | | | | | $ | (86) | | | | | $ | (37,471) | | | | | $ | 21,829 | | |
| | |
Six Months Ended
June 30, |
| |||||||||
|
2020
|
| |
2021
|
| ||||||||
|
(USD in thousands)
|
| |||||||||||
經營活動: | | | | | | | | | | | | | |
Net loss for the period
|
| | | $ | (6,739) | | | | | $ | (10,912) | | |
非現金項目調整
|
| | | | 735 | | | | | | (908) | | |
Income taxes received
|
| | | | 812 | | | | | | — | | |
Interest paid
|
| | | | — | | | | | | (3) | | |
營運資金變動前的經營活動現金流
|
| | | | (5,192) | | | | | | (11,823) | | |
營運資金變動產生的現金流: | | | | | | | | | | | | | |
淨營運資金變動
|
| | | | (61) | | | | | | 300 | | |
經營活動中使用的淨現金
|
| | | | (5,253) | | | | | | (11,523) | | |
投資活動: | | | | | | | | | | | | | |
無形資產投資
|
| | | | (35) | | | | | | (60) | | |
購置物業和設備
|
| | | | (74) | | | | | | (792) | | |
非流動金融資產 - 租賃保證金收(付)款
|
| | | | (17) | | | | | | 30 | | |
投資活動中使用的淨現金
|
| | | | (126) | | | | | | (822) | | |
融資活動: | | | | | | | | | | | | | |
股票發行收益
|
| | | | — | | | | | | 27,900 | | |
與發行股票相關的交易成本
|
| | | | — | | | | | | (2,605) | | |
Leasing installments
|
| | | | (36) | | | | | | (78) | | |
由融資活動提供/(用於)融資活動的淨現金
|
| | | | (36) | | | | | | 25,217 | | |
現金和現金等價物淨增加/(減少)
|
| | | | (5,415) | | | | | | 12,872 | | |
1月1日的現金和現金等價物
|
| | | | 9,559 | | | | | | 5,834 | | |
現金和現金等價物的匯率調整
|
| | | | (59) | | | | | | 93 | | |
6月30日的現金和現金等價物
|
| | | $ | 4,085 | | | | | $ | 18,799 | | |
Assets
|
| |
Useful life
|
|
Properties | | | 資產的租賃期限和使用壽命較短 | |
Other equipment | | | 3 – 6 years | |
| | |
Number of
warrants |
| |
Weighted Average
Exercise Price/Share (DKK) |
| ||||||
Warrants granted as at December 31, 2019
|
| | | | 1,932,156 | | | | | | 1 | | |
Warrants granted
|
| | | | – | | | | | | 1 | | |
Warrants forfeited
|
| | | | (45,216) | | | | | | 1 | | |
Warrants cancelled
|
| | | | (22,032) | | | | | | 1 | | |
Warrants granted as at June 30, 2020
|
| | | | 1,864,908 | | | | | | 1 | | |
Warrants exercisable as at June 30, 2020
|
| | | | – | | | | | | − | | |
| | |
Number of
warrants |
| |
Weighted Average
Exercise Price/Share (DKK) |
| ||||||
Warrants granted as at December 31, 2020
|
| | | | 2,228,076 | | | | | | 1 | | |
Warrants granted
|
| | | | 63,809 | | | | | | 1 | | |
Warrants forfeited
|
| | | | (7,566) | | | | | | 1 | | |
Warrants cancelled
|
| | | | (10,404) | | | | | | 1 | | |
Warrants granted as at June 30, 2021
|
| | | | 2,273,915 | | | | | | 1 | | |
Warrants exercisable as at June 30, 2021
|
| | | | – | | | | | | − | | |
| | |
Number of
Ordinary Shares |
| |
Share Capital
(DKK in thousands) |
| ||||||
Share capital, December 31, 2020
|
| | | | 16,198,668 | | | | | | 16,198 | | |
2021年2月9日首次公開發行增資
|
| | | | 3,000,000 | | | | | | 3,000 | | |
Share capital, June 30, 2021
|
| | | | 19,198,668 | | | | | | 19,198 | | |